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“Don’t fear failure.   
Not failure, but low aim,  
is the crime.  
In great attempts it is 
glorious even to fail.” 
– Bruce Lee  
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Understanding the molecular basis of life has been in the spotlight of 
biochemistry research for more than a century already. Molecular biology 
has taken medicine forward thanks to technological breakthroughs like DNA 
sequencing and CRISPR editing. However, in order to understand 
metabolism we must rely on the study of metabolite profiles and metabolic 
reactions. The purpose of this thesis is to contribute to this area, which 
unites the fields of proteomics and metabolomics. Traditionally, omics data 
analysis treats variables independently even if it is strongly settled that 
molecular mechanisms involve the interaction of diverse pathways, 
therefore data should be analyzed correspondingly. A vast amount of 
metabolic pathways have been described, together with enzymes that are 
responsible for metabolite transformations, this information has been 
assembled in databases that, in turn, can be used to build metabolic 
networks. 
In here, we use metabolic networks to predict metabolite dysregulation 
based on quantitative proteomics profiles. To validate the predictions, it is 
possible to measure the abundance of metabolites or their flux, namely the 
rate at which they are transformed, using stable isotope labelling 
experiments, both measurements can be performed by metabolomics. In 
this thesis, two different metabolomics-based stable isotope labelling 
approaches have been developed, one for the study of central carbon 
metabolites and one for the unbiased detection of deregulated fluxes in 
other metabolic pathways. These approaches have been tested on different 
datasets and have proven valuable to obtain remarkable results, unraveling 
molecular mechanisms in diabetes complications or novel metabolic 
hallmarks of cancer.  
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La biologia molecular ha avançat considerablement gràcies a importants 
progressos com la seqüenciació del ADN o la seva modificació per 
CRISPR. Tot i això, per entendre el metabolisme requerim estudiar els 
perfils metabòlics i les seves reaccions metabòliques. L’objectiu d’aquesta 
tesi és contribuir en aquest estudi del metabolism, el qual unifica dels 
camps de la proteòmica i la metabolòmica. Tradicionalment, l’anàlisi de 
dades òmiques es basa en el tractament independent de les diferents 
variables encara que està profundament establert que els mecanismes 
moleculars són controlats per la interacció de diferents molècules, i per tant 
seria més correcte tractar les dades de la mateixa manera. Avui dia, s’han 
descrit una gran quantitat de vies metabòliques, incluint els enzims 
responsables de les transformacions dels metabòlits que les formen, 
aquesta informació s’ha recopilat en bases de dades, que a la vegada 
poden ser utilitzades per a construir xarxes metabòliques.  
En aquesta tesi, s’han utilitzat xarxes metabòliques per a desenvolupar un 
algoritme que prediu metabòlits desregulats basant-se en el perfil 
d’expressió d’enzims gràcies a proteòmica quantitativa. Per a validar tals 
prediccions, és possible mesurar l’abundància d’aquests metabòlits, o el 
seu flux, o sigui la velocitat a la que s’han transformat, utilitzant experiments 
de marcatge amb isòtops estables, mesures completades mitjançant 
metabolòmica. Aqui, mostrem els productes del desenvolupament de dos 
mètodes per a l’anàlisi de dades de metabolòmica per a experiments amb 
isòtops estables: el primer per a la quantificació dirigida del flux en 
metabòlits del metabolisme central; i un segon, per la detecció no-dirigida 
de metabòlits marcats amb isòtops en altres vies metabòliques. Aquests 
mètodes han sigut provats en diferents estudis on han aportat resultats 
remarcables, revelant nous mecanismes moleculars en una complicació de 
la diabetes o en relació al metabolisme del càncer. 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
 
10 
 
  
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
 
11 
 
 
 
 
 
 
 
 
 
 
LIST OF TABLES AND FIGURES 
  
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
 
12 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
LIST OF TABLES AND FIGURES 
13 
 
 
Table 1. Human protein enzymes in Uniprot database .............................. 31 
Table 2. Mass analyzers and their capabilities .......................................... 42 
Table 3. Metabolomics databases for identification ................................... 83 
Table 4. Bioinformatic tools for MS/MS “in silico” identification. ................. 86 
Table 5. Genome-scale metabolic models. ............................................... 91 
Table 6. Pathway enrichment analysis from IMPALA. ............................. 125 
Table 7. Isotopologues to consider in HRMS for Lactate 2TMS .............. 151 
Table 8. Compounds resolved using CI-isobutane detection and 
quantification. ................................................................................. 154 
 
  
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
LIST OF TABLES AND FIGURES 
14 
 
 
Figure 1. Diagram of parts of mass spectrometers. .................................. 40 
Figure 2. Targeted acquisition modes. ..................................................... 46 
Figure 3. Summary of proteomics workflows ............................................ 57 
Figure 4. Metabolomics workflows, fishing for biomarkers. ....................... 66 
Figure 5. Stable isotope labelling. ............................................................ 95 
Figure 6. Conventional proteome analysis.............................................. 115 
Figure 7. Extraction of reaction, reactants and their associated genes 
and proteins for Recon 2 SBML and KEGG databases. ................. 118 
Figure 8. Venn diagrams depicting the result of reaction filtering for 
metabolic network building in KEGG and Recon 2. ........................ 119 
Figure 9. SBML files from Recon 2 ......................................................... 120 
Figure 10. Recon metabolic networks. ................................................... 121 
Figure 11. Summary of the quantitative proteomic analysis on RPE 
cells.. ............................................................................................. 122 
Figure 12. Interrogating the metabolic network with proteomics. ............ 124 
Figure 13. Lipidomics results .................................................................. 127 
Figure 14. Example of dysregulated metabolite (glutathione) ................. 128 
Figure 15. Significantly altered in Asparagine N-linked glycosylation 
pathway. ........................................................................................ 128 
Figure 16. Trans-sulfuration and one carbon metabolism pathways ....... 129 
Figure 17. Ketone body metabolism. ...................................................... 130 
Figure 18. Comparison of Lactate 2TMS spectra ................................... 141 
Figure 19. Chemical ionization and isobutane advantages ..................... 142 
Figure 20. Spectra obtained for Citrate 4TMS in EI 15eV and 70eV 
ionization ....................................................................................... 144 
Figure 21. EICs obtained for corresponding Lactate 2TMS 
isotopologues. ................................................................................ 145 
Figure 22. Isotopologue abundances relative deviation in relation to 
theoretical natural abundances detected in a triple quadrupole. ..... 146 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
LIST OF TABLES AND FIGURES 
15 
 
Figure 23. Isotopologue abundances relative deviation in relation to 
theoretical natural abundances detected in QTOF and qOrbitrap 
instruments.................................................................................... 147 
Figure 24. Comparison of relative abundances of isotopologue ions ..... 148 
Figure 25. Data input and function hierarchy in isoSCAN ...................... 150 
Figure 26. Workflow for geoRge experiments. ....................................... 166 
Figure 27. Representation of geoRge’s principle. .................................. 167 
Figure 28. Comparative analysis of geoRge and X13CMS. ..................... 173 
Figure 29. Summary of the effect of hyperglycemic conditions on  
ARPE-19 cells ............................................................................... 174 
Figure 30. Labelling pattern of sugar-containing compounds. ................ 177 
 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
16 
 
  
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
 
17 
 
 
 
 
 
 
 
 
 
 
 
LIST OF PUBLICATIONS 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
 
18 
 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
LIST OF PUBLICATIONS 
19 
 
Capellades J, Navarro M, Samino S, Garcia-Ramirez M, Hernandez C, 
Simo R, Vinaixa M, Yanes O (2015) “geoRge: A computational tool to detect 
the presence of stable isotope labelling in LC/MS-based untargeted 
metabolomics” Analytical chemistry. 88:621-628. 
Vinaixa M, Rodríguez MA, Aivio S, Capellades J, Gómez J, Canyellas N, 
Stracker TH, Yanes O (2017) “Positional Enrichment by Proton Analysis 
(PEPA): A One‐Dimensional 1H‐NMR Approach for 13C Stable Isotope 
Tracer Studies in Metabolomics” Angewandte Chemie International Edition. 
56:3531-3535.  
Senan O, Aguilar-Mogas A, Navarro M, Capellades J, Noon L, Burks D, 
Yanes O, Guimerà R, Sales-Pardo M (2019) ”CliqueMS: A computational 
tool for annotating in-source metabolite ions from LC-MS untargeted 
metabolomics data based on a coelution similarity network” Bioinformatics 
Bueno MJ, Jimenez-Renard V, Samino S, Capellades J, Junza A, López-
Rodríguez ML, Garcia-Carceles J, LopezFabuel I, Bolaños JP, Chandel NS, 
Yanes O, Colomer R, Quintela-Fandino M. (2019) “Essentiality of fatty acid 
synthase in the 2D to anchorage-independent growth transition in 
transforming cells” Nature Communications, 10 (1), 5011. 
Llinàs-Arias, P, Rosselló-Tortella, M, López-Serra, P, Pérez-Salvia, M, 
Setién, F, Marin, S, Muñoz, J P, Junza, A, Capellades, J, Calleja-
Servantes, M E, Ferreira, H J, De Moura, M C, Srbic, M, Martínez-Cardús, 
A, De La Torre, C, Villanueva, A, Cascante, M, Yanes, O, Zorzano, A, 
Moutinho, C Y Esteller, M (2019) “Epigenetic loss of the endoplasmic 
reticulum–associated degradation inhibitor SVIP induces cancer cell 
metabolic reprogramming” JCI Insight, 4(8) 
  
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
LIST OF PUBLICATIONS 
20 
 
Soukupova J, Malfettone A, Hyroššová P, Hernández-Alvarez MI, Peñuelas-
Haro I, Bertran E, Junza A, Capellades J, Giannelli G, Yanes O, Zorzano A, 
Perales JC, Fabregat I (2017) “Role of the Transforming Growth Factor-β in 
regulating hepatocellular carcinoma oxidative metabolism” Scientific 
Reports. 2;7(1):12486.  
 
 
  
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
 
21 
 
 
 
 
 
 
 
 
 
 
LIST OF ABBREVIATIONS
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
 
22 
 
 
  
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
LIST OF ABBREVIATIONS 
23 
 
ARPE-19  Human retinal pigment epithelial cell line 
ATP  Adenosine triphosphate 
BRB Blood retinal barrier  
BSS Blind source separation  
CE Capillary electrophoresis  
CI Chemical ionization  
CID Collision-induced dissociation 
CV Coefficient of variation  
DDA Data-dependent acquisition  
DESI Desorption electrospray ionization 
DM Diabetes mellitus  
DR Diabetic retinopathy 
EC Enzyme Code 
EIC Extracted ion chromatograms 
ESI Electrospray ionization 
FAMEs Fatty acid methyl esthers  
FC Fold change 
FDR False discovery rate  
FTICR Fourier transform ion cyclotron resonance  
GC Gas chromatography 
GPR Gene-Protein-Reaction rules 
H25 Hyperglycemia and hypoxia 
H5 Normoglycemina and hypoxia 
HILIC Hydrophilic interaction chromatography  
HMDB Human Metabolome Database 
LC Liquid chromatography 
LIT Linear ion trap  
LTQ Linear quadrupole ion trap 
MA Methoxyamine 
m/z mass-to-charge ratio 
MIM Multiple ion monitoring 
MS Mass Spectrometry 
MS/MS Tandem mass spectrometry 
MSI Metabolomics Standards Initiative  
mzRT Peak with unique m/z and a specific retention time 
N25 Hyperglycemia 
N5 Normoglycemina and normoxia 
NADPH  Nicotinamide adenine dinucleotide phosphate 
NIST National Institute of Standards and Technology 
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NMR Nuclear magnetic resonance 
ORA Overrepresentation analysis  
PAGE Polyacrilamide Gel Electrophoresis 
PCA Principal component analysis  
PDR Proliferative diabetic retinopathy  
PPI Protein-protein interaction 
PRM Parallel reaction monitoring 
PTM Post translational modulation 
QC Quality control  
QIT quadrupole ion trap  
Q-TOF Quadrupole-TOF  
QqQ Triple quadrupole 
QTrap Triple-quadrupole ion trap  
RP Reversed-phase  
RT Retention time 
SAH S-Adenosylhomocysteine  
SAM S-Adenosylmethionine  
SIM Single ion monitoring 
SCX Strong cation exchange 
SD Standard deviation 
SDS Anionic sodium dodecyl sulfate 
SILAC Stable isotope labelling by amino acids in cell culture 
TCA Tricarboxylic acid  
TMS Trimethylsilyl 
TMT Tandem mass tags  
TOF Time of flight  
TQ Triple quadrupole  
UPLC Ultra performance liquid chromatography 
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1. METABOLISM AND ENERGY 
1.1 The role of energy in biochemistry 
All living organisms must obtain and use energy to live, grow, reproduce 
and eventually evolve. At the cellular level, this energetic demand is 
commonly supplied via the transformation of chemical substrates. 
Metabolism can be defined as the collection of life-sustaining chemical 
reactions in living organisms.1 Metabolism plays a central role in life being 
the source of energy and building blocks for cellular growth as well as 
ensuring protection against stress factors. Metabolism has evolved to 
support function of the cell and can roughly be divided into three functional 
modules: central carbon metabolism, biosynthetic pathways and secondary 
metabolism.2 
Organisms can perform a wide variety of metabolic reactions with great 
efficiency. Chemical compounds taking part in these reactions are referred 
to as metabolites. Carbohydrates, nucleotides, amino acids, and lipids are 
among others examples of metabolite families whose atomic composition 
and structure vary as much as their physico-chemical properties and roles in 
the cell.1 Metabolites can also be combined to form more complex 
macromolecules, such as DNA, RNA and proteins, that acquire whole new 
biochemical properties and functionalities.    
 
1.2 Metabolic reactions  
In living organisms, homeostasis is maintained through regulation of gene 
expression and enzyme activity, which, in turn, control metabolic fluxes 
when cells require a higher production of a given compound or family of 
compounds. Different molecular mechanisms regulate all these interlocked 
metabolic processes simultaneously, obtaining every product in the amount 
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needed and at the right time. Such control involves a variety of mechanisms 
operating at different time scales, in order to properly adjust metabolic 
fluxes when environmental conditions change. If homeostasis fails, disease 
or death is often the consequence. 
Metabolic reactions are bioenergetic processes, and as any other energy 
exchange processes, are subject to the laws of thermodynamics. 
Thermodynamic laws and molecular properties are the foundations of 
metabolic reactions in a living organism, yet evolution has only brought 
nature a limited number of reaction options compared to those used in 
organic chemistry labs. In general, these reactions can be3: 
● Catabolic. Breaking down larger molecules to release energy and to 
generate precursors for further reactions. 
● Anabolic. Combining molecules together to generate biologically 
useful molecules and biopolymers. 
● Interconversions. In which there is no change of order but instead 
functional groups or isomer configurations are swapped between 
molecules. 
Metabolic reactions can be artificially organized in schematic maps that 
interconnect compounds in so called metabolic pathways. In a metabolic 
pathway, the product of one reaction is connected to the following reaction 
as a reactant, normally associated with information regarding genes and 
proteins that control such reaction. Biochemists and biologists have 
classified metabolic pathways depending on their main metabolic purpose, 
though it must be taken into account that they are all interconnected, and 
thus free exchange of metabolites happens between them, except if they 
are compartmentalized in certain organelles. Therefore, metabolism can be 
viewed as a collection of metabolic pathways in which the concentrations of 
products and reactants are constantly fluctuating to balance reactions. 
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Thus, although the rate of metabolite transformation, or flux, through any 
step of the pathway may be high and variable, the concentration of 
substrate remains typically constant. This ability of maintaining the 
intracellular concentrations within limited boundaries is known as 
homeostasis.1 Balancing reaction kinetics is necessary in living organisms, 
otherwise their metabolic systems would collapse.  
 
1.3 Enzymes and enzymatic reactions 
In metabolic reactions, the elements responsible for the transformation of 
metabolites are a family of protein macromolecules known as enzymes. 
Enzymes themselves are also under tight regulation, which involves a 
combination of regulators in the form of other proteins and gene processes. 
When a chemist performs a reaction in the laboratory, diverse parameters 
can be applied to increase the yield or rate of a reaction, including 
temperature, pressure or the use of catalysts. In contrast, most biological 
systems carry out reactions at the temperature maintained by the organism 
and at atmospheric pressure3. This is possible because biological systems 
use enzymes are molecular catalysts. An enzyme drives the reaction by 
providing a specific environment in which a given reaction can occur more 
rapidly, in other words, enzymes make the reaction thermodynamically 
favorable. Many biochemical reactions, such as the formation of the amino 
peptide bond in a protein, would be otherwise unfavorable in isolation. Thus, 
in order to drive the reaction forward, biochemical systems often couple 
reactions with a positive-free energy change to those with a large negative-
free energy change.3 Enzyme structure contains a highly specific substrate-
binding site that acts lowering the energy of high energy species along the 
reaction intermediates from starting material to product. This physical 
pocket in the enzyme structure is known as the active site.1 
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Generally, enzymes are proteins, macromolecules of medium or high 
molecular weight made up of amino acids by peptide bonds. Their amino 
acid composition defines their (1) folded tridimensional structure due to non-
covalent interactions and (2) an enzymatic activity, determined by one or 
more amino acid motifs, evolutionarily conserved sequences of amino acids, 
or patterns of sequences, that are characteristic of certain type of enzymatic 
reactions.  A second group of macromolecules which also have enzymatic 
activity are RNA molecules, known as ribozymes. Ribozymes were 
discovered in the 1970s, when the first RNA molecule was found to have 
catalytic activity proving that nucleic acids are more than mere passive 
carriers of information.1 Even though ribozymes do not strictly participate in 
metabolic reactions themselves, their action is essential for other processes 
related to transcription and translation. 
Since enzyme naming is ambiguous and there is an ever-increasing number 
of newly discovered enzymes, biochemists have adopted a system for 
naming and classifying enzymes by international agreement. Enzymatic 
reactions are classified by the scientific community using the EC (Enzyme 
Consortium) codes which define the type of reactions that occur, the 
substrates, the products and even the cofactors necessary for it to happen.1 
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Table 1. Human protein enzymes in Uniprot database4 per main 
enzyme class. 
Main enzyme 
class 
Class function Number of 
subgroupsin 
class 
Number of 
human 
proteins 
*Reviewed  
EC 1. 
Oxidoreductases 
Transfer of  
electrons 
25 558 
EC 2. 
Transferases 
Transfer of 
functional groups 
10 1825 
EC 3. 
Hydrolases 
Molecule 
hydrolysis  
13 1606 
EC 4. Lyases Non-hydrolytic 
addition or 
removal of groups 
from substrates 
8 156 
EC 5. 
Isomerases 
Isomerization, 
rearrangement of 
functional groups 
6 122 
EC 6. Ligases Molecular binding 6 125 
EC 7. 
Translocases 
Movement of 
molecules across 
or through 
membranes 
6 63 
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1.4 Enzymatic regulation 
Continuing with the chemistry lab analogy, the function of a catalyst is to 
increase the rate of a reaction without affecting the equilibrium of the 
reaction. Consequently, to control the reaction equilibrium cells have 
different strategies to regulate the availability of the elements that participate 
in the reaction. Firstly, the concentration of substrates and products can be 
controlled by regulating their import and export from and to the environment 
or between intracellular compartments. Secondly, enzymes can be 
regulated through:1 
● Transcription and translation regulation. One of the strategies to 
control the concentration of an enzyme is through their genetic 
expression, i.e. modulating their transcription and translation 
processes. Gene expression and protein expression are regulated at 
different molecular levels, for example using transcription factors, 
enhancers and RNA modification. Once folded into a functional 
protein, enzymes can also be regulated by localization, inhibition and 
post-translational modifications mechanisms. 
● Localization. Since cells are highly organized living systems, 
reactions themselves are inevitably too, meaning that reactions are 
compartmentalized in certain parts of the cell. Therefore, if enzymes 
are locked in a different part of the cytoplasm different from the 
reactants, their availability is limited until it is necessary. 
● Inhibition. Another example of enzymatic control is the use of 
inhibitors, molecules that are able to interact with the enzyme 
structure or its active site. Enzyme inhibitors interfere with catalysis, 
slowing or halting enzymatic reactions. Depending on the type of 
bond, inhibitors are either reversible or irreversible, yet three types of 
reversible inhibition exist:  
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○ Competitive inhibitors bind to the enzyme’s active site that 
prevents binding of the substrate to the enzyme. 
○ Uncompetitive inhibitors bind at a separate site but bind only to 
the enzyme-substrate complex. 
○ Mixed inhibitors bind at a separate site, but may bind to either 
the enzyme or the enzyme-substrate complex. 
● Post translational modification (PTM). Finally, enzyme activity can 
also be controlled by modifying the functional groups of their amino 
acid sequence. The introduction of a charged chemical group or a 
different functional group can alter the local properties of the enzyme 
and induce a change in conformation, which can affect the activation 
status of the enzyme, its localization or its affinity to/for a substrate.1 
PTM modifying groups include a wide range of small chemicals such 
as phosphoryl, acetyl, methyl, glucosyl, but also larger modifications 
including ubiquitin and sumo proteins. 
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2. BIOMEDICINE AND OMIC 
SCIENCES 
2.1 From biochemistry to molecular biology 
Compiling and contrasting all the information about life has taken centuries 
of hard work done by biologists, physicians, chemists, physicists, 
mathematicians, biochemists and molecular biologists. Early and mid 20th 
century represented the “golden age of biochemistry” when the foundations 
of molecular biology were laid.3  
First, pathways responsible for nutrient utilization and energy production in 
humans and other organisms were delineated. This was followed by 
important landmarks such as protein composition and DNA structure 
characterization among others. This led to definition of the central dogma of 
molecular biology stating a simplified gene-transcript-protein relationship. 
The progressive discovery of the function of biomolecules drawn the 
attention of biomedical research, which was traditionally focused on 
studying genetic variants and mutations that are associated with different 
diseases.3 Common diseases were understood in terms of inherited or 
somatic mutations that impact gene expression, signal transduction, cellular 
differentiation and other processes not traditionally viewed in bioenergetic or 
metabolic terms.5 However, current evidence is showing that many 
metabolic perturbations accompany human diseases causing major 
worldwide burden such as cancer or type 2 diabetes.  
A completely refurbished view of metabolism is gaining ground. This is 
nowadays regarded as a highly-organized network of metabolic reactions, 
meaning that a perturbation of almost any part of metabolism results in a 
global response in which a large number of enzymes have to alter their 
regulation to maintain homeostasis.2 In other words, metabolism impacts, 
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and is impacted by, virtually every other cellular process when responding 
to cellular needs.5 Consequently it is clear that there is a need to go 
downstream translation to be able to explain complex diseases where fully 
functional gene variants, instead of mutations, may predispose the 
individual to suffer from a certain condition. The combined effect of such 
gene variants and environmental conditions defines the pathological 
observable phenotype. Modern biomedical research aims at understanding 
the causes and mechanisms leading to such pathological phenotypes at the 
molecular level. To this end, ‘omic’ sciences have been progressively 
introduced.6 
 
2.2 The family of omic sciences 
Since the discovery of the structure of DNA, molecular biologists got more 
and more interested in understanding biology in detail at the molecular level. 
This led to the development of technology capable of recovering the 
sequence of DNA, the detection of molecules with tiny masses or the 
characterization of protein binding and its dynamics, giving birth to omic 
sciences and thus, modern biomedicine. 
Omic sciences are a family of interdisciplinary sciences that focus on the 
generation of a comprehensive profiling of different kinds of molecules in a 
cell culture, tissue or organism. The output of omic technologies may 
include information about abundance, identity and modifications of the 
analyzed molecules. Omic sciences can be applied not only for greater 
understanding of normal physiological processes but also in disease where 
they play a role in screening, diagnosis and prognosis as well as aiding our 
understanding of the etiology of diseases.  
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Depending on the family of molecules studied, omic sciences can be briefly 
divided into:7 
● Genomics is the systematic study of an organism’s genetic DNA 
material. Genomics studies normally involve the characterization of 
genomes in order to compare gene sequences, their variants and 
regulators across species or generations.  
● Transcriptomics studies gene expression and gene variability 
through gene’s RNA transcripts. Additionally, non-coding RNA 
analysis gives information about their regulatory mechanisms. 
● Epigenomics is the study of epigenetic modifications on the DNA 
and histones. These modifications play an important role in gene 
expression and regulation. 
● Proteomics aims to understand the functional relevance of proteins, 
including their modifications and interactions. The proteome is 
defined as the set of all expressed proteins in a cell, tissue or 
organism. 
● Metabolomics can be defined as the study of metabolite profiles. 
The metabolome is the final downstream product of gene 
transcription and protein expression, therefore, the metabolome is 
closest to the phenotype. 
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3. MASS SPECTROMETRY-BASED 
OMICS 
3.1 Mass spectrometers 
Mass spectrometry (MS) is a technology applied to measure the abundance 
of molecular ions in a sample. MS has become invaluable across a broad 
range of fields and applications, including metabolomics and proteomics. In 
the end, both metabolomics and proteomics measure ionized molecular 
species that are obtained by ionizing either metabolites, peptides or 
proteins, respectively.  
Mass spectrometers are an heterogeneous family of instruments capable of 
ionizing, filtering and measuring the abundance of ions present in a sample. 
Mass spectrometers typically consist of the following elements: inlet, source, 
mass analyzer and an ion detection module.8,9 
● Sample inlet. This is an injection system that is used to introduce 
the content of a sample vial into the ionization source. The pump 
may be either manual in the case of direct injection or connected to a 
chromatography system working at high pressures (see Section 3.3). 
● Ionization source. In which sample analytes are subjected to a 
physico-chemical process that produces ions suitable for resolution 
in the mass analyzer, this process is known as “ionization” and takes 
place in gas phase. This process involves the generation of charged 
molecules from sample compounds through an energy transfer, 
generating charged molecular ions from the original molecule. There 
are two main types of ionization methods: soft ionization methods 
leave the structure of the original molecule relatively unharmed, while 
hard ionization methods cause fragmentation of the compound 
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molecular structure into smaller fragment ions.  
The most common ionization method for small molecule and peptide 
analysis is electrospray ionization (ESI), a soft ionization method that 
uses desolvation through a current at high voltage to produce 
charged molecular ions. Other soft ionization approaches such as 
atmospheric pressure chemical ionization (APCI) and atmospheric 
pressure photon ionization (APPI) are also used, mainly in 
metabolomics. These ionization methods use either a molecular 
reaction by interaction with a reagent gas in the former, or ultraviolet 
light in the latter.   
In the case of GC/MS-based metabolomics experiments, it is 
possible to utilize electron ionization (EI) as well as chemical 
ionization (CI) with different reagent gases. EI is a highly 
reproducible hard ionization technique with extended use in GC/MS, 
while CI has more of a niche use.  
Finally, in the case of MS imaging (MSI), a technique that acquires 
MS spectra from bidimensional solid matrices, matrix-assisted laser 
desorption/ionization (MALDI), desorption electrospray ionization 
(DESI) and secondary ion mass spectrometry (SIMS) are different 
technologies, each with its own ionization particularities, but all apply 
an ionization energy onto a solid sample instead of a liquid or gas.14 
● Mass analyzer. Mass analysers can be separated into two main 
groups: (i) trapping mass spectrometers such as ion trap (IT) or 
Orbitrap and (ii) ion-beam mass spectrometers, such as TOF and 
quadrupoles. The main difference is that trapping systems resolve 
ions discontinuously while ion-beam instruments do it continuously.10 
○ There are many types of mass analyzers, using either static or 
dynamic fields, and magnetic or electric fields, but all operate 
according to a differential equation of motion of charged 
particles: the Lorentz law.   
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Ion trap (IT), Orbitrap, and ion cyclotron resonance (ICR) mass 
analyzers separate ions based on their m/z resonance 
frequency, while quadrupoles (Q) use m/z stability and time-of-
flight (TOF) analyzers use time. In consequence, each analyzer 
possesses different acquisition capabilities that can be tuned 
depending on the objectives of the analysis: 11 
■ Resolution. A metric that measures the amount of mass 
units that the analyzer is capable of distinguishing 
between two neighboring ion peaks. 
■ Sensitivity. A qualitative indicator of the minimal amount of 
analyte that the analyzer detects. It can be quantitatively 
determined using a dilution series, and it is reported as the 
limit of detection. 
■ Scan speed/rate. The frequency at which the instrument is 
recording ion abundances, depending on the architecture 
of the analyzer and the detector, this speed can go from 1 
to 100 Hz. 
■ Mass accuracy. A quantitative measure of how similar the 
recorded m/z value is to the true m/z ion. This difference is 
expressed in parts per million (ppm).  
■ Response range. It is the range of absolute abundance 
units at which the detector operates, in which we can 
distinguish: (a) dynamic range, the concentration range 
which gives a measurable response that goes from the 
limit of detection to saturation; and the (b) linear range, 
that is the concentration range at which the response of 
the detector is linear, and thus considerably more reliable.  
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■ Mass range. It is the range of m/z values at which the 
analyzer performs with maximal mass accuracy and 
sensitivity. Some instruments sacrifice mass range in 
order to maximize scan rate and resolution.  
● Mass detector. The detector records the charge induced or a 
change in current produced when an ion passes by or hits a surface, 
these are associated to abundance of the previously measured 
molecular ions, a task solved by the instrument software. There are 
different types of detector hardware yet they are generally chosen to 
match the performance of the mass analyzer.  
 
 
Figure 1. Diagram of parts of mass spectrometers.  
In order to improve the capabilities of mass spectrometry systems, hybrid 
instruments emerged, which balance the advantages and limitations of 
different instrument types. For instance, triple-quadrupole instruments are 
still very limited in resolution and mass accuracy, but they offer a high 
dynamic range and excellent sensitivity, which make them ideal instruments 
for peptide and small molecule quantitation in targeted analyses. 
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 Plus, a hybrid of the highly efficient quadrupole and a highly accurate and 
resolving Orbitrap is ideal for both peptide and small molecule 
detection/identification.10 
Additionally, ion mass filter technology (as in quadrupoles) or the ability to 
perform ion fragmentation via tandem mass spectra (see Section 3.2) are 
also valuable features of hybrid mass spectrometers. Other useful utilities 
are the ability to shift between positive and negative polarity modes, 
meaning that they can detect positively or negatively charged ions, some 
instruments may be even capable of shifting at high rates. 
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Table 2. Mass analyzers and their capabilities (Adapted from Junot 
et al. 12). i.c, internal calibration; e.c., external calibration 
Mass 
analyzer 
type 
Max 
resolving 
power 
(FWHM) 
Mass 
accuracy 
(ppm) 
Max scan 
rate (Hz) 
Max 
mass 
range 
Dynamic 
range 
(Log10 
AU range) 
QqQ 7.500 5 5 3.000 5-6 
IT/LIT 10.000 50 30 4.000 4 
qLIT 9.000 50 20 2.000 5-6 
TOF 20.000 1 (i.c.) 40 20.000 4-5 
IT-TOF 10.000 2 (i.c.) 10 40.000 3-4 
qTOF 60.000 2 (i.c.) 100 40.000 4-5 
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Orbitrap 
(Exactive) 
200.000 
1 (i.c.) 
3 (e.c.) 
8-15 
*Depends 
on 
resolution 
6.000 4-5 
LTQ-
Orbitrap 
240.000 
1 (i.c.) 
3 (e.c.) 
5-10 
*Depends 
on 
resolution 
4.000 3-4 
qOrbitrap 150.000 
1 (i.c.) 
5 (e.c.) 
8-12 
*Depends 
on 
resolution 
4.000 3-4 
LTQ-FT-
ICR (7T) 
750.000 
<1 (i.c.) 
1 (e.c.) 
1-5  
*Depends 
on 
resolution 
4.000 3-4 
qFT-ICR 
(7T) 
1.000.000 
<1 (i.c.) 
<1.5 
(e.c.) 
1-5 
 
10.000 3-4 
LIT-
qOrbitrap 
(IDX) 
500.000 
1 (i.c.) 
3 (e.c.) 
40 
*Depends 
on 
resolution 
2.000 3-4 
qTOF 
(Agilent 
6546) 
60.000 1 (i.c.) 30 40.000 5-6 
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3.2 Tandem mass spectrometry 
Omics technologies play an important role in biomarker discovery as well as 
in other stages of the drug discovery and development (e.g. target 
discovery, mechanism of action or predicting toxicity). In particular, recent 
progress in tandem mass spectrometry techniques have helped facilitate the 
realization of the inherent power of proteomics and metabolomics in 
biomarker discovery, validation and qualification.13 
In mass spectrometry, the mass-to-charge ratio is a non-informative 
measure of molecular ion structure, thus this magnitude is hardly traceable 
into a compound name in metabolomics or amino acid sequence of a 
peptide in proteomics. In order to attain such objectives, a further level of 
information can be obtained through fragmentation of molecular ion 
structure using tandem mass spectrometry. 
Tandem mass spectrometry, also known as MS/MS or MS2, involves three 
distinct steps of (1) selection of a single or multiple ion/s, (2) fragmentation 
and (3) mass separation of fragments. The fragmentation and separation of 
fragments may take place in a different space in the case of instruments 
that contain collision cells such as QqQ, qTOF, or hybrid ion trap/FTMS 
instruments; or scan time through ion accumulation in ion traps, Orbitrap 
and FT-ICR MS.14 
In the case of small molecules, as in metabolites, the structure of each 
parent/precursor molecular ion generates a pattern of fragments, or product 
ions, that are highly specific, but not necessarily unique. On the other hand, 
MS/MS is used in proteomics to fragment peptide or protein ions in order to 
elucidate their amino acid sequence, useful indeed for protein identification. 
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3.3 Tandem mass spectrometry acquisition modes 
The acquisition of MS/MS is strictly tied to the hardware design of the mass 
spectrometer, in which we can distinguish three different methods 
depending on how the precursor ions are selectively fragmented: targeted, 
data dependent and data independent acquisition methods. In most cases, 
tandem mass spectrometry is applied in mass spectrometers coupled to 
separation systems in order to be efficiently perform and improve the quality 
of results.  
3.3.1 TARGETED ACQUISITION MODES 
In mass spectrometry, targeted analysis implies the selection of a few 
precursor ions, reporting their relative abundance or absolute concentration 
by extrapolating their abundance on a calibration curve. Targeted methods 
are characterized by having high sensitivity, wide dynamic range, reliable 
quantification accuracy and stability. However, their setup is so complex that 
they are generally restricted to a low number of preselected analytes. 
A few MS strategies exist for targeted analysis in which the quantification is 
based on full scan mode, meaning that no fragmentation is applied, and 
instead the abundance of a preselected ion is used for quantification. In 
these, tandem mass spectrometry is not used for identification and instead a 
previously characterized retention time serves as a guide to quantify 
previously selected ions in methods known as selected ion monitoring (SIM) 
in single quadrupoles or multiple ion monitoring (MIM) in triple quadruples or 
quadrupole-ion trap hybrids.15  
MS/MS fragmentation brings further advantages since this technology can 
be applied to monitor and fragment multiple parent ions and study the 
fragmentation pattern for greater specificity. These include Multiple reaction 
monitoring (MRM), or Selected Reaction Monitoring (SRM). SRM is typically 
performed on a triple quadrupole mass spectrometer, which for long has 
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been used for targeted quantification. SRM is the most used strategy for 
targeted quantification in both metabolomics and proteomics.15 Also, a 
similar strategy can also be applied on a Q-Orbitrap instrument, known as   
 
Parallel Reaction Monitoring (PRM), which allows simultaneous scanning of 
an entire group of fragment ions at higher resolution than a triple 
quadrupole.15 
 
Figure 2. Targeted acquisition modes. Based on Figure 5 from 
Junot et al.12  
3.3.2 DATA DEPENDENT ACQUISITION MODES 
Modern hybrid instruments have been upgraded with automatable utilities. 
One of them is the ability to record and filter some ions and then near 
instantly perform a fragmentation routine for those filtered. This augments 
the amount of data that can be extracted from a single chromatographic run, 
including precursor ions and their corresponding fragmented spectrum, yet 
these approaches have certain limitations.   
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Data Dependent Acquisition (DDA) implies that fragmentation is only 
affected if an ion complies with a certain condition in the full scan mode, 
meaning that in DDA the instruments are sequentially switching between full 
scan (MS1) and MS2 modes. There are different criteria that can be used to 
trigger DDA acquisition routines:8,16  
● Ion intensity-dependent acquisition. It uses an intensity threshold 
to trigger sequential MS/MS acquisition, if a precursor ion exceeds a 
predefined threshold of intensity fragmentation occurs. 
● Accurate-mass inclusion list-dependent acquisition. In here a list 
of accurate masses of expected or predicted metabolites is used to 
trigger MS/MS acquisition.  
● Isotope pattern-dependent acquisition. This method takes 
advantage from the fact that certain atoms generate unique isotopic 
patterns that can be easily recognized in their mass spectra to trigger 
MS/MS acquisition.  
● Pseudo neutral loss-dependent acquisition. This DDA experiment 
consists in the generation of pairs of full scans, one at low collision 
energy (i.e., 5 eV) followed by another scan with a higher collision 
energy ramping (i.e., 20–40 eV), and monitors characteristic m/z 
differences of ion-pairs (neutral loss) between consecutive low and 
high collision energy full-scan MS. This can be used to obtain MSMS 
spectra for a subset of a characterized family of metabolites. 
● Mass defect-dependent acquisition. Mass defect filter (MDF) was 
developed to facilitate the detection of both common and uncommon 
metabolites. 
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3.3.3 DATA INDEPENDENT ACQUISITION MODES 
This approach provides fragment ion information in a non-selective manner 
by fragmenting all precursor ions within a defined mass range.17 It requires 
novel mass spectrometers with fast duty cycles and acquisition times with 
up to 100 MS/MS scans per second at medium-high mass resolving power. 
In DIA, all precursor ions in a predefined isolation window (from several Da 
to a full mass range) are sequentially isolated to acquire multiplexed MS2 
spectra and ensure to acquire MS2 spectra for all ions in MS1 scan.18 
One advantage is that they do not require to be triggered by any event rule 
(as in data-dependent MS/MS), but the main drawback is that co-eluting 
molecules with higher intensities (that are usually triggered first in data-
dependent MS/MS) and lower abundant ions are still fragmented altogether, 
incrementing data complexity. Therefore, an obvious disadvantage for this 
type of analyses is that the direct link between a specific precursor ion and 
its corresponding product ions is broken, thus these methods produce highly 
complex MS/MS spectra that require specific data processing software 
tools.16,17 DIA methods include: 
● Elevated energy MS (MSE) approach using Q-TOF. This approach 
involves alternating between two full-scan functions, one at low 
collision energy and the other at a higher collision energy range. The 
mass spectra from low collision energy provide intact molecular ion 
information, while high collision energy spectra contain fragmentation 
data useful for structural elucidation. 
● All-ion fragmentation using Orbitraps. In which a wide range of 
precursor ions are first recorded and then sent into the HCD cell 
where they are fragmented. 
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● Sequential Windowed Acquisition of All Theoretical Fragment 
Ion Mass Spectra’ (SWATH™) acquisition. This technology takes 
advantage of the fast scan speed and narrow selectivity ranges of 
TOF Sciex (TripleTOF™) mass analyzers, in which the instrument 
fragments all ions across a given mass range in sequential narrow 
ranges (20-50 Da) as they elute.16 SWATH allows a reduction of 
simultaneously fragmented precursor ions, therefore, decreasing the 
complexity of MS2 spectra. As a result, the effort to reconstruct the 
connections between the precursor and product ions is also 
alleviated. 18 
3.3.4 MULTI-STAGE TANDEM MASS SPECTROMETRY 
Last but not least, ion-trap and FT-ICR type instruments are capable of 
generating multi-stage mass spectrometry (MSn) spectra, in which MS2 
product ions are trapped allowing another isolation and fragmentation to be 
performed, in MSn this cycle can be performed multiple (n) times. MSn 
generates a list of interrelated MS/MS spectra, also known as ion trees or 
mass spectral trees, which contain the precursor-product relationships of 
the different MSn acquisition rounds. 
3.3.5 TECHNICAL CONSIDERATIONS 
There are two different fragmentation modes for small biomolecule MS/MS-
based experiments: collision-induced dissociation (CID) in quadrupoles and 
higher energy collisional dissociation (HCD), specific of orbital ion trap mass 
spectrometers. Both CID and HCD fragmentation methods result in 
complementary fragmentation information because of the different hardware 
technologies that are implemented in the respective collision cells.8  
There are two main parameters in the case of tandem mass spectrometry 
that have a great impact on the resulting fragmentation spectrum. First, the 
“collision energy” plays an important role in MS/MS spectra generation, 
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especially in CID. Low collision energies preserve most of the precursor ion 
structure and only few product ions are observed, whereas increasing the 
collision energy naturally increase product ion abundances toward low m/z 
ranges, i.e. smaller fragments. Therefore, using a set of different 
complementary energies is a better source of structural information.  
Another important aspect is the “precursor ion isolation width” of the mass 
selector, since it has an impact on both sensitivity and selectivity during 
MS/MS data acquisition. In general, selecting narrow precursor ion isolation 
windows (high resolution precursor isolation) lowers the sensitivity of the 
precursor ion and thus the intensity of fragment ions.  In contrast, widening 
the isolation window leads to the fragmentation of a larger number of 
different compounds and results in impure product ion spectra with 
interfering ions.  
 
3.4 Separation techniques coupled to mass spectrometry 
In a single drop of sample, thousands of molecular ions can potentially be 
detected using a mass spectrometer, but mass-to-charge values would 
overlap and impede the extraction of ion abundance. Therefore, separation 
techniques such as chromatography and capillary electrophoresis have 
been developed to be coupled with mass spectrometry since their main 
purpose is to, over time, separate compounds based on their physical and 
chemical properties.  
3.4.1 CHROMATOGRAPHY 
Chromatography is a separation technique that consists in the use of a 
mobile phase and stationary phase in order to separate or even purify 
certain analytes found in an heterogeneous mix. The applications of 
chromatography are endless, both in research and industry. In the family of 
omic sciences, both proteomics and metabolomics use chromatography for 
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analyte separation prior to mass spectrometry, an instrument setup named 
“hyphenated mass spectrometry”. The stationary phase chemically and 
physically interacts with the analytes in a sample until the mobile phase 
progressively washes them away in a process known as elution. The 
amount of time that a single analyte requires to be completely washed away 
is called elution time, or retention time, such time depends on the strength 
of the interaction of the analyte with the solid phase and how the mobile 
phase interferes with such interaction.  
Chromatographic separation of analytes prior to MS analyses has several 
advantages:9 
● It reduces matrix effects and ionization suppression, side-effects of 
the ionization procedure from complex samples. 
● It is capable of separating isomers. 
● It allows for more accurate quantification of separated analytes. 
3.4.1.1 Liquid Chromatography 
Liquid chromatography (LC) is a separation technique in which the mobile 
phase is a liquid and the stationary phase is a solid surface, that is variable 
depending on the analytes to be separated. The technology evolved in what 
is known as high-performance liquid chromatography (HPLC), which utilizes 
very small packing particles and a relatively high pressure to maintain a 
stable and relatively fast flux through the column. 
In the last decades chromatographic columns evolved to pack  sub-2μm 
particles, requiring much higher pressures, leading to the definition of ultra-
high performance liquid chromatography (UHPLC)19, also UPLC, capable of 
better resolved peaks compared to HPLC and in shorter run times. 
Additionally, in the case of proteomics, a need for high sensitivity using low 
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amounts of sample yielded extremely low flow rate systems known as 
nanoLC.19 
Historically LC has been divided into two different subclasses based on the 
polarity of the mobile and stationary phases. Methods in which the 
stationary phase is more polar than the mobile phase are termed normal 
phase liquid chromatography (NPLC) and the opposite method is termed 
reversed phase liquid chromatography (RPLC).19 
In proteomics and metabolomics, RPLC is the most common approach 
used. There is a wide range of applications using RPLC because of the 
various mobile and stationary phases20, being C18 silica column using an 
acidic water/organic mobile phase the standard choice.21 In C18-bonded 
silica columns, the selectivity of non- and moderately polar compounds can 
vary greatly depending on the density of C18 alkyl chains, the accessibility 
of silanol, or the presence of bonding groups between the silica beads and 
C18 alkyl groups.  
However, chromatography technology has increased the specificity of 
methods using novel column material designs. A particular example of novel 
chromatography techniques is Hydrophilic interaction liquid chromatography 
(HILIC), which utilizes highly polar stationary phases capable of forming a 
water-rich layer in which  hydrophilic solutes are retained based on their 
polar, ionic and hydrogen bonding interactions.19 It is a unique type of NPLC 
chromatography method that can be used to increase coverage of the polar 
metabolome. The order of elution is inverted compared to RPLC, with 
hydrophilic compounds being retained longer than hydrophobic 
compounds.21 A plethora of HILIC column stationary phases have been 
developed and can be separated in four categories: anionic, cationic, 
uncharged and zwitterionic.21 HILIC separation is used in both 
metabolomics and proteomics for different reasons. In metabolomics, it has 
proven suitable for the separation of polar and hydrophilic metabolites21, 
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whereas in proteomics HILIC is used as an alternative to ion exchange 
chromatography and for targeted analysis of PTMs.23  
3.4.1.2 Gas chromatography 
Gas chromatography (GC) is a chromatography separation technique in 
which the mobile phase and the sample are found in a gas phase. GC is a 
separation method specific for low weight compounds as it only is capable 
of analyzing volatile compounds, or those that can be chemically modified to 
be volatile and thermally stable by derivatization.24 
In gas chromatography, the sample is vaporized and injected into the head 
of the separation column that then it traverses by the flow of an inert gas 
employed as the mobile phase. This inert gas is usually helium or an 
unreactive gas such as nitrogen, although hydrogen is preferred for 
improved separations. The separation depends on how compounds are 
adsorbed on the surface of the stationary phase. The stationary phase may 
be a solid adsorbent, in the case of gas–solid chromatography, or a liquid 
coating for gas–liquid chromatography. The latter is the most widely used 
GC technique in metabolomics, due to superior performance and suitability 
for metabolites. In  gas–liquid chromatography, the liquid stationary phase is 
adsorbed onto a solid inert packing or immobilized on the capillary tubing 
walls:24 
 The column is considered packed if the glass or metal column tubing 
is filled with small spherical inert supports. The packing is an inert 
support impregnated with 5–20% stationary liquid phase in a thin 
layer. These liquid phases are primarily silicone-based oils with high 
temperature stability. 
 In a capillary column, tubing walls contain highly absorbent materials 
that form a thin film of liquid stationary phase that coats their inner 
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wall. Because the tube is open, its resistance to flow is very low, and 
it is thus referred to as an open tubular column. 
Capillary columns although more expensive are a better option for complex 
mixtures, they offer various advantages relative to packed columns. Higher 
density and surface of separative elements leads to far superior resolution 
plus faster and more efficient separation. 
Optimizing GC separation requires fine-tuning of a number of variables and 
their interactions. Both physical (internal diameter, length, and stationary 
phase) and parametric (temperature and flow velocity) column variables 
affect the separation process in metabolomics. A range of stationary phases 
can be applied to metabolome analysis in GC/MS, although methyl-phenyl 
columns are typically applied (e.g., 95:5 methyl/phenyl and 50:50 
methyl/phenyl), plus their length (from 5 to 100 m) and diameter (<0.1 to 
>0.5 mm) is also variable.25 In general, most methods use narrow bore 
fused-silica capillaries with wall-coated 5%(diphenyl)- polydimethylsiloxane 
(PDMS) as a generic non-polar stationary phase and He as an inert gas 
with elution gradient programs performed with a maximum temperature 
under 320 °C within 50 min to reduce column bleed; however, some reports 
also utilize more polar stationary phases for improved selectivity in GC/MS 
and/or higher peak capacity in 2D GC × GC/MS, such as 50%(diphenyl)-
PDMS and 14%(cyanopropylphenyl)- PDMS bonded phase columns.19 
3.4.2 CAPILLARY ELECTROPHORESIS 
Capillary electrophoresis itself is not strictly a chromatography separation as 
it lacks a stationary phase, though CE-MS represents a niche separation 
technique used in both metabolomics and proteomics.19 In CE, analytes 
migrate through electrolyte solutions under the influence of an electric field, 
separated according to their intrinsic electrophoretic mobility, which is 
dependent on the charge and size of the analyte. CE–MS is often 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
INTRODUCTION 
55 
 
considered a technically challenging approach and limited by poor 
concentration sensitivity and migration time variability.26 
CE is applied for resolution of highly polar, charged and labile ions that have 
poor retention in RP-LC or require complicated sample handling prior to 
GC/MS, for example multivalent charged ions. Therefore it is reserved for 
the analysis of special types of multiply charged metabolites or proteins, it  
has been used for the global and reproducible profiling of native peptides 
and some metabolites in a clinical setting.26  
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4. PROTEOMICS 
Proteins are an incredibly diverse family of molecules even if their sequence 
can merely be formed by only 20 different amino acids, their order and 
location in the peptide sequence lead to significantly different protein types, 
conformations and isoforms, plus the modification of amino acid side chains 
affects their functionality and stability. Proteomics generally focuses on the 
global identification and quantification of protein molecules in biological 
samples. In addition, proteomics also is interested in the study of protein-
protein interactions and protein post-translational modifications (PTM). 
In a similar manner to metabolomics, proteomics has been growing in terms 
of throughput due to improved protein extraction protocols and MS 
instrument development.29 Though, totally different methodologies may be 
used to study other protein-related molecular dynamics, these include cell 
imaging by light and electron microscopy for cellular location, or array and 
chip experiments for interaction. 30  
 
4.1 Mass spectrometry-based proteomics 
4.1.1 INSTRUMENTATION  
Electrospray ionization (ESI) and matrix-assisted laser desorption/ionization 
(MALDI) are the two techniques most commonly used to ionize proteins or 
peptides for mass spectrometric analysis.29 
Due to the large collection of protein types in complex biological samples, 
samples need to be simplified prior to protein analysis in order to facilitate 
the subsequent steps of the workflow. Additionally, enzymatic digestion of a 
full proteome, usually done by trypsinization, generates hundreds of 
thousands of peptides. In consequence this level complexity is not 
compatible with direct MS analysis.29 Therefore, the first step in most 
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proteomics workflows aims at reducing the sample complexity either by 
separation, prefractionation or enrichment. 50 
It is important to consider that single-dimension peptide chromatography 
does not provide sufficient peak capacity to separate peptide mixtures as 
complex as those generated by proteolysis of protein mixture.29 With the 
evolution of liquid chromatography technology, LC/MS has been of great 
importance to proteomics, since sensitivity and selectivity are further 
improved due to enhanced sampling of peptides into the mass 
spectrometer.11 In proteomics, two-dimensional or even three-dimensional 
chromatographic separations of peptide mixtures are used in LC-MS/MS, 
normally a combination of  RPLC, HILIC, ion exchange or affinity 
chromatography separations.29 
4.1.2 PROTEOMICS STRATEGIES 
 
Figure 3. Summary of proteomics workflows to analyze a sample 
containing a protein mixture. In blue preparation steps prior to 
detection technologies (red) 
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There are two main approaches in the field of MS proteomics:11,29 
● Top-down proteomics consists in the implementation of MS analysis 
sampling intact proteins, its main advantage is that it reduces the 
ambiguities tied to the identification of bottom-up or peptide mass 
mapping approaches, plus it is capable of distinguishing between 
isoforms. Normally, top down proteomics is applied to highly purified 
protein samples, e.g. single proteins or simple protein mixtures. 
Therefore, the source of proteins for top-down analysis may be either 
a 2DE or 1DE combined with specific LC fractionation.31 
● Bottom-up proteomics, also shotgun proteomics, is used in the case 
of high-complexity samples for large-scale analyses, normally 
applying to quantitative strategies. In bottom-up proteomics, proteins 
are enzymatically digested into peptides prior to mass analysis, then 
peptide masses and sequences are used to identify corresponding 
proteins. Drawbacks of the bottom-up approach include limited 
protein sequence coverage by identified peptides, loss of labile 
PTMs, and its main bottleneck which is the elucidation of protein 
identification from peptide sequences.31  
4.1.3 QUANTITATIVE PROTEOMICS 
In order to compare across different sample groups, MS peptide abundance 
measurements must be somehow normalized. In quantitative proteomics, 
samples containing differently labelled proteins or peptides are combined 
and analyzed by LC-MS/MS for the purpose of identifying what proteins are 
contained in the sample and determining their relative abundance between 
groups.  Although relative quantification reveals changes in protein levels 
between two or more states, it is dimensionless and is normally expressed 
in the form of ratios. Recent advances in MS and bioinformatics now allow 
the estimation of the absolute amount of proteins: that is, the copy number 
of proteins per cell. 30  
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There is a great collection of methods for protein labelling in quantitative 
proteomics, that can be divided depending on the mechanisms that are 
used to label sample proteins:30 
● In ‘stable-isotope labelling with amino acids in cell culture’ (SILAC) 
proteins are labelled metabolically by culturing cells in media that are 
isotopically enriched (for example, containing 15N salts, or 13C-
labelled amino acids). Potentially all peptides can be labelled and the 
absence of any chemical steps make the method easy to apply as 
well as compatible with multistage purification procedures.29 
● In the case of isotope coded affinity tag (ICAT), proteins in each 
condition are labelled with chemical probes that consist of three 
elements: a reactive group for amino acid labelling, an isotopically 
coded linker, and a tag (e.g., biotin) for the affinity isolation of 
labelled proteins/peptides.11 
● In isobaric labelling methods, such as iTRAQ, dimethyl labelling or 
TMT-labelling, proteins are labelled at specific sites with isotopically 
encoded reagents. The reagents may also contain affinity tags, 
allowing for the selective isolation of the labelled peptides after 
protein digestion. Thus enabling their selective isolation and analysis 
of to specific functional groups or protein classes. 
● In enzyme-catalyzed stable isotope labelling proteins are tagged by 
means of an enzymatic incorporation of 18O from 18O water during 
proteolysis in the presence of deuterated water. In this method, 
peptides are labelled at the carboxy terminal when digested.  
On the other hand, label-free protein quantification is also an option, yet 
label-free quantification through spectral counting and/or signal intensity of 
the detected peptides seems to be the less ideal way to obtain quantitative 
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information, as it suffers from all the drawbacks of mass spectrometry in 
terms of variability and linearity of the detector’s response.30  
Additionally, absolute protein quantification can be achieved by targeted 
proteomics methods using SRM, MRM or PRM methods to enable 
reproducible, sensitive and selective protein assays, that are relatively faster 
to develop and deploy than immunoassays. Even though they are limited to 
a lower coverage, as it is restricted by manual curation of proteolytic 
peptides for each targeted protein, it is in principle capable of distinguishing 
highly similar proteoforms such as isoforms, post-translationally modified 
proteins and genetic variants. 11  
4.1.4 PROTEIN IDENTIFICATION 
The main issue in protein identification in proteomics results from the 
challenge of elucidating peptide sequences from LC-MS/MS spectra and 
their subsequent inferred protein entities. The identification of a protein by 
elucidating the series of fragmented peptides is a complex task tied to 
stochastic statistics and probability. In high throughput experiments, this 
process is performed “in silico”  in two steps:29,30 
 The extraction of peptide sequences from CID MS/MS spectra can 
be accomplished by either searching into existing peptide spectral 
databases, or alternatively it can be achieved by directly determining 
the sequence of peptides by analyzing the spectra. Based on 
stochastic rules of peptide fragmentation and the fact that amino 
acids have a known fixed mass, a strategy known as “de novo” 
sequencing. 
 Protein identification is solved by algorithms that infer protein 
identifications based on the peptides sequences detected. This task 
entails distinguishing correct peptide assignments from false 
identifications. Incorrect peptide assignments can be prevented by 
applying filtering criteria based upon database search scores. 
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However, the rates of false identifications that result from such filters 
are hard to determine. Consequently, it is therefore important that 
computational approaches use robust and transparent statistical 
principles to estimate accurate probabilities indicating the likelihood 
of identification. The most common approach is the combination of 
precursor m/z and its fragment ions that are matched to known 
peptide sequences from large protein databases using search 
algorithms such as Mascot or SEQUEST, and then use decoy 
search strategies, in which the MS/MS spectra are competitively 
matched against random databases to estimate the rate of false 
positive identifications.  
 
4.2 Result interpretation 
Proteomics experiments often generate a vast amount of data. However, 
the simple identification and quantification of proteins is not sufficient for the 
full understanding of complex mechanisms occurring in the biological 
systems. Protein functional annotation through computational tools now 
occupies a place as important as the protein identification itself. There are 
different strategies for protein contextualization:32 
● Gene ontology-based annotation. Genome and proteome 
ontologies are designed with hierarchical classes, communicating 
definitions with clarity and objectivity, however, keeping extendibility. 
Ontologies for genes and proteins usually describe the classification 
of the molecules according to their role in the biological systems, 
using controlled vocabulary. As a result, collections of protein entities 
are associated to relevant biological information such as functionality 
or cellular compartmentalization.  
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● Functional enrichment analysis for identification of 
overrepresented biological mechanisms. This approach increases 
the probability of identifying the most pertinent biological processes 
related to a biological mechanism under study. The goal of this 
approach is to summarize the biological processes and pathways 
that are most likely altered given the protein profile. Enrichment 
scores can be calculated by statistical methods, including Chi-
square, Fisher's exact test, Binomial probability and Hypergeometric 
distribution. 
● Integration of functional annotations through biological network 
analysis. The main purpose of this approach is to facilitate the 
visualization of the results. Proteomics data is displayed in networks 
built from knowledge-based databases that contain different 
biological layers of information, such as gene expression and co-
expression patterns, protein–protein interactions and coregulation. 
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5. METABOLOMICS 
The metabolome is defined as the collection of small molecules produced 
by cells, metabolites, it is therefore a direct source of information to study 
the biochemistry of organisms. Unlike genes and proteins, whose function is 
respectively subject to epigenetic regulation and post-translational 
modifications, metabolites serve as direct signatures of biochemical activity 
and they are therefore easier to correlate with a phenotype.33 
In this context, metabolomics has become a powerful approach that has 
been widely adopted for clinical diagnostics, revealing molecular 
mechanisms underlying drug action, dietary changes, exercise intervention 
and psychosocial impacts of environment. Moreover, it plays a vital role in 
systems biology for elucidating the function of unknown genes and 
enzymes.19   
 
5.1 Metabolomics strategies  
The main concern in the experimental design of a metabolomics study is 
actually deciding the number of metabolites that should be measured. This 
somewhat depends on whether it is possible to localize the source of 
metabolic variation, aka metabolic pathway(s) that are affected by a given 
perturbation or challenge. The type of approach used will determine the 
subsequent analytical protocols.33  
5.1.1 UNTARGETED METABOLOMICS 
Untargeted metabolomics methods aim to simultaneously and unbiasedly 
measure as many relevant metabolites as possible from biological samples. 
This is usually reserved to biologically relevant molecular features, in other 
words, metabolite ions that show differential abundance profiles detected by 
rigorous data preprocessing and statistical analysis.33  
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The uniqueness of untargeted metabolomics is that it suits “hypothesis-free” 
testing for discovery of unknown or poorly characterized metabolites of 
some type of biological or clinical significance. In summary, untargeted 
metabolomics offers novel insight into complex metabolic mechanisms of 
drug/toxin action or characterization of complex diseases.19 Hyphenated-MS 
platforms have become the setup of choice for most untargeted 
metabolomics experiments given their higher sensitivity. In relation to 
instrument setups for MS untargeted studies, metabolite quantification 
requires a compromise between sample throughput, metabolome coverage, 
peak quality  and peak capacity.19 While the equipment used in MS 
untargeted metabolomics varies, chromatography instruments are normally 
coupled to high-resolution MS equipment that operates at a high scan 
speed since it is ideal to record the finest peak profiles possible during the 
chromatographic run. Given the limitations of coverage of each 
chromatography method, in most cases, orthogonal chromatography 
separation modes are used in parallel to analyze the same sample as a way 
to expand metabolome coverage. In the case of polar and nonpolar 
metabolites, these include HILIC-LC/MS and RP-LC/MS, in aggregate with 
GC/MS.34 
5.1.2 TARGETED METABOLOMICS 
Targeted metabolomics refers to any analytical method in which a specified 
list of metabolites is measured. Targeted approaches are commonly driven 
by a specific biochemical question or a hypothesis that motivates the 
investigation of a particular metabolic pathway. Methodologically, targeted 
metabolomics involves an important analytical effort in order to optimize 
chromatographic separation and ionization responses, commonly done 
using a commercial standard or a pure extract of the targeted metabolites.42 
Targeted approaches provide a highly sensitive and robust method to 
proficiently measure dozens of biologically important metabolites with  
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relatively high throughput, therefore analytical platforms used in targeted 
metabolomics require good sensitivity and specificity in order to measure of 
low-concentration metabolites that are difficult to detect with alternative 
methods.19 Additionally, targeted methods are quantitatively reliable and 
hence they are sometimes used to achieve absolute quantitation.33 Absolute 
quantification can determine the exact molarity for given metabolites in a 
sample, yielding analytical results independently of the experimental 
context. To achieve absolute quantification, a calibration curve for each 
targeted metabolite needs to be constructed using a range of several 
dilutions. 
5.1.3 SEMI-TARGETED METABOLOMICS 
 It is defined as an “expanded” targeted metabolomics approach that has 
been proposed for quantitative analysis of hundreds of known standard 
metabolites, often across multiple analytical platforms, in order to cope with 
the drawbacks of untargeted approaches while retaining comprehensive 
metabolome coverage. 
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Figure 4. Metabolomics workflows, fishing for biomarkers. 
Targeted quantification methods are represented as fishing hooks, 
while untargeted approaches are similar to a fishing net.  
 
5.2 Sample preparation 
An indispensable element of any metabolomics protocol involves the 
extraction of analytes, metabolites, from the studied samples, such as body 
fluids, cells, and fresh or fixed tissue. The goal of extraction is to obtain 
quantitative yields of metabolites in the sample, and remove impurities, i.e. 
proteins.  
Extraction protocols may vary depending on the experimental design, the 
nature of the sample, targeted molecules to be detected and the analytical 
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platform used. An optimal metabolite extraction method ultimately leads to a 
higher extraction efficiency and analytical sensitivity. However, an increased 
number of preparatory procedures and fractionation may reduce the analytic 
throughput.34 There are two main types of extraction methods: liquid-liquid 
and solid phase extraction. The former is widespread used in both targeted 
and untargeted approaches because of its superior throughput and 
reproducibility.25 
Extraction methods are designed to exploit a property which differs in the 
analytes of interest and the rest of extraneous material. In summary, sample 
preparation includes:15 
 Enrichment for metabolites of interest: The most common extraction 
solvents include a combination of water, methanol, acetonitrile, 
methyl tert-butyl ether and/or chloroform. 
o It is important to consider that sample extraction targets a 
subset of the metabolome to be extracted from raw 
specimens. Extraction protocols are normally classified 
depending on whether the metabolites to be extracted are (a) 
polar or (b) non-polar. In other words, no single extraction 
method satisfactorily covers the entire metabolome.15 
 Removal of impurities that interfere with analysis such as proteins 
and salts: Protein precipitation is generally achieved by mixing with 
cold solvents such as acetonitrile, ethanol or methanol in acidic or 
basic pH, in order to cause denaturation and thus reduce their 
solubility. 
5.3 Mass spectrometry-based metabolomics 
In MS metabolomics, the nature of the data detected depends on multiple 
factors. First metabolomics MS techniques can be divided depending on the 
how the sample is injected in the mass spectrometer.  
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Samples can be directly injected to mass spectrometers, a technique known 
as direct infusion (DI-MS).35 Alternatively, a separation technique can be 
used previous to MS analysis, this family of techniques are known as 
hyphenated MS. Analytes that enter the mass spectrometer are previously 
separated by a gas-, liquid chromatography (GC and LC, respectively) or 
capillary electrophoresis (CE).33 It must be considered that, similar to the 
diversity of conditions for metabolite extraction, no single chromatographic 
method is suitable for all classes of metabolites. Since the metabolome is 
composed of a diverse array of compounds with different physicochemical 
properties, no single retention mechanism is adequate to resolve complex 
sample mixtures that vary widely in their polarity, charge, and stability.15 
Finally, metabolites found in biological samples, such as tissue or organ 
slices, can also be ionized from a solid surface, or solid-like matrix, 
providing information on the physical localization of analytes in sample as 
the spectra is associated to a certain area of the surface, SIMS, DESI and 
MALDI are MS techniques used to that end, for example in the field of 
“tissue imaging”.36,37 
5.3.1 LC/MS METABOLOMICS 
LC/MS metabolomics is the method that brings the widest metabolome 
coverage, from small metabolites to large lipids. Such immense coverage 
comes from the variety of chromatography columns together with recent 
developments in sensitivity and mass accuracy, LC-MS/MS have been 
applied to high accuracy instruments typically used in untargeted 
metabolomics.38 Normally, LC/MS instruments used in metabolomics are 
UHPLC systems coupled to hybrid high resolution instruments, such as the 
qTOF and Orbitrap, in which the standard method of ionization is ESI. 
Recent developments in LC column technology have greatly improved 
separation efficiency while expanding selectivity, yet chromatographic 
separations are not universal for the metabolome.  
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Therefore, different combinations of chromatography column and mobile 
phases setups must be used to increase the coverage of any LC/MS 
metabolomics experiment. The most common chromatographic separation 
is RP, but lately metabolomics interest in HILIC has grown given its 
complementarity to RP analysis. Additionally, the separation of metabolites 
can be tuned by modifying the chromatographic separation time or the use 
of mobile phase modifiers (ammonium formate or ammonium acetate), so 
as to improve the separation stability and efficiency of LC/MS, and improve 
the MS detection sensitivity.15 
5.3.2 GC/MS METABOLOMICS 
In the case of low molecular weight metabolites, GC/MS has revealed as a 
method of choice to detect not only volatile but also non-volatile polar and 
non-polar metabolites, though its coverage is still significantly lesser than in 
LC/MS.  
GC/MS metabolomics relies on the application of chemical derivatization to 
analyze most polar and lower weight metabolites. Chemical derivatization 
can be applied to obtain a broader metabolome coverage to increase 
metabolite stability and volatility. There are a few derivatization methods, yet 
the most common approach involves a two-step procedure, first the 
methoximation of the ketone groups and the silylation of all protonated 
radicals (alcohols, carboxylic acids, amines, thiols, and phosphates). 
Interestingly, trimethylsilylation remains as the most widely used derivatizing 
procedure in GC/MS-based metabolomics given its general applicability to 
various classes of polar metabolites.19 Though, there exists no derivatization 
method that leads to one derivative per metabolite for all compound classes.  
Even though there is a great variety of column lengths, diameter and 
capillary types, 30 m long 0.25 mm internal diameter 95% dimethyl/5% 
diphenyl polysiloxane, and similar, are the standard choice for GC/MS 
metabolomics.39 In the case of MS detectors, TOF and single quadruple are 
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more common, yet higher resolution instruments, such as Orbitrap, may 
also be used.40,41 Unlike ESI ionization used in LC/MS, Electron Impact (EI) 
is the standard ionization method used in GC/MS, that does not suffer from 
ion suppression or differential adduct formation.15 Besides, the 
fragmentation spectrum generated by EI is highly reproducible and an 
analogue to tandem mass spectra in the case of metabolite identification. 
5.3.3 CHARACTERISTICS OF METABOLOMICS DATA 
The extraction of metabolite abundance out of spectral data is an important 
task in metabolomics. While data analysis in targeted metabolomics is 
nowadays rather a manual and demanding task aided by commercial 
software regularly distributed along with the instruments. It is, in contrast, 
truly a challenge in untargeted metabolomics since the datasets are 
exceedingly complex in terms of the knowledge of data analysis needed to 
extract biological information.25 Nonetheless, it is accepted in the community 
that quality of data processing can be difficult to assess since there is not 
any standardized benchmark, thus it relies on data analysis traceability and 
reproducibility.43 
In MS metabolomics, acquisition instruments generate data files which 
contain a collection of successively recorded ion histograms. Each 
histogram represents counts of ionized molecules impacting the detector 
during a short time frame (scan), each ion is recorded as a value of mass-
to-charge ratio (m/z) eluting at a certain time point.43 
Due to the intrinsic dynamics of ionization events, ion quantification and 
limitations of chromatographic separation, untargeted metabolomics data 
has a few inherent properties that make it noisy and redundant, these 
features vary depending on the experimental design and platform used, yet 
they must always be considered in untargeted metabolomics data analysis 
pipelines : 
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 Adducts. A common issue in MS spectra is the presence of adducts 
during the event of ionization. Especially in LC/MS where 
electrospray ionization (ESI) during the desolvation process in the 
source, yet it also occurs in the rest of soft ionization techniques. 
This occurrence, together with the detection of natural isotope 
variants of molecules, increase the number of recorded ion m/z 
peaks, meaning that spectra contain many more ion features than 
actual compounds.44  
Adduct formation cannot be controlled, yet it can be favored by 
controlling the composition of the mobile phase. Adduct type is 
molecule dependent and adducts themselves have different sources 
depending on: salt concentrations, mobile phases, solvents, 
impurities from glassware or the sample matrix itself.44 Dimers or 
even trimers may appear predominantly in the source, which are 
concentration dependent, plus they are highly expected if hydrogen 
bonds are possible within the molecule.44 Finally, some ions may 
appear multicharged, increasing the challenge of compound 
annotation.  
 Isotopes. It is common to detect naturally occurring isotopes in MS 
metabolomics, especially in the case of 13C, yet in very high 
resolution instruments 15N, 18O or 32S must also be considered 
among other atom isotopes. Their presence correlates with 
molecular ion abundance and they can potentially mask other ion 
signals.25 
 Retention time shifts. The chromatographic separation equipment 
is inherently sensitive to changes in temperature and atmospheric 
pressure, meaning that in datasets with a large number of samples, 
metabolite retention time is inevitably subject to variation. 
Additionally, retention time shifts may result from anomalies in the 
flow rate, mobile phase composition and column age.44 
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 Mass accuracy. Due to detector limitations, mass spectrometers 
have a window of accuracy when measuring the mass-to-charge 
ratio of ions, meaning that the true value is within an error tolerance 
that depends on the instrument type and its calibration.  
 Noise. MS spectra may also contain a variable amount of chemical 
noise that has different sources: impurities from buffers and 
solvents, column/tube degradation species, especially in the solvent 
front and at the end of the run during column washing. In addition, 
spectra contain random noise, typical of electronic devices, which 
can be attributed to the detector response variation caused by its 
maintenance status, atmospheric pressure or temperature.43 The 
main drawback of noise is that it may shift the signal baseline, 
altering the threshold of intensity that differentiates noise from true 
ion signals.44 
 Performance variation over time. Closely related to RT shifts and 
noise, it defines the event of a gradual loss of response in the MS 
detector. It is a common side-effect of instrument usage and 
contamination of the detection hardware, the MS counts recorded 
may vary over time, leading to false intensity records that are lower 
than expected.25  
 
5.4 Data processing  
5.4.1 RAW DATA TRANSFORMATION 
Data processing consists in low-level processing of raw data using signal 
processing methods and combining data between measurements. These 
tasks transform raw series of scans into a format that is easy to use in the 
subsequent data analysis steps.43 
In general, MS instruments store data in vendor specific formats that are 
designed to be used in the corresponding vendor software. However, the 
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community made an effort to design a unique open data format to 
standardize open source software for data analysis, this format is known as 
mzML, previously mzXML45 The transformation of vendor formats into 
mzML is a common first step in metabolomics data processing.  
Using mzML file format, raw data can be imported into data processing 
software or coding environments. In these, raw data points are transformed 
into simplified data structures, e.g. matrix and additional metadata that 
facilitate easy access to characteristics of each observed ion. These 
characteristics include intensity measurement, m/z and elution time, 
commonly named retention time, of the ions recorded in each raw data file. 
The matrix obtained contains three dimensions: m/z, retention time and 
intensity; different in each sample. The difficulty in this process originates 
from the fact that algorithms must account for considerable variations in 
their chromatographic peak shape, peak time span and m/z accuracy.46 
A large collection of software exists for untargeted metabolomics data 
analysis, each with its own strengths and weaknesses, yet most of them 
involve some, or all, of the following data processing steps:43 base line 
removal, peak detection/filtering and retention time alignment. 
5.4.2 PEAK DETECTION 
The purpose of peak picking, or mass trace detection, is to extract as many 
recorded signals, caused by true molecular ions, i.e. metabolites, as 
possible. This is done by sequentially checking for ion recordings in which 
their intensity fits to a model of an ideal shape of an eluting compound, this 
model normally includes a gaussian-like function. This step also aims to 
provide accurate quantitative information about ion abundance.43 
Noise filtering/smoothing and baseline removal are essential steps of peak 
detection, they involve mathematical noise reduction methods designed to 
remove random noise from the measurement signal while finding the signal 
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baseline shape and finally subtracting the shape from the raw signal.43 
These methods are typically implemented using traditional signal processing 
algorithms such as: moving average window, median filter, Savitzky-Golay 
local polynomial fitting and wavelet transformation.47 
On the other hand lies deconvolution, an algorithm-based process designed 
to reverse the effects of convolution, a mathematical operation that 
combines two differently shaped functions. Deconvolution methods have 
been typically used in metabolomics to extract different compounds that 
coelute forming a complex elution peak. The main challenge in the use of 
deconvolution methods is that complex biological matrices lead to a large 
number of overlapping peaks, with similar retention times and overlapping 
isotope patterns. Deconvolution algorithms utilize the assumptions that 
different fragments from the same molecule have the same retention time 
as well as that their profiles across multiple samples are highly correlated 
since they are subject to the same biological variation and systematic 
error.47,48 Such methods have been widely used in GC-EI-MS data 
processing, and also have been applied to LC-DIA-MSMS. In a way, 
deconvolution is in itself a peak picking and retention time adjustment 
approach altogether. This signal processing technique estimates the relative 
area corresponding to each individual peak when multiple peaks overlap 
within the same spectral region.47 This strategy involves finding raw data 
components that are subsequently matched over the different observations, 
but its main requirement is the presence of several mass traces that 
converge at the same retention time for deconvolution, thus ideal for DIA-
MS and EI-MS.49 
5.4.3 SAMPLE ALIGNMENT 
Spectral alignment is one of the main processing steps in untargeted 
studies involving datasets with tenths or hundreds of samples. When 
analyzing multiple samples, the retention time of compounds corresponding 
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to the molecular ion peak may be affected by non-linear shifts.47 Spectral 
alignment methods must be therefore applied to correct this undesired 
variation in the samples that can profoundly affect the quality of the study, 
they can be divided in two main groups depending on whether the algorithm 
uses a reference list of peaks to perform the alignment. However, the choice 
of alignment method usually dictates the type of required downstream data 
analysis. Some alignment methods allow the analysis of aligned raw signals 
directly for finding differences between samples, while other alternatives 
lead to multivariate data analysis.43 
Referenced alignment algorithms involve the use of an existing peak list to 
direct the RT correction of the shifts. This reference list may either be one of 
the other samples or a meta sample created by mixing all previously 
detected peaks. Pair-wise methods use raw data as input material and 
generate a set of mappings that transform retention time axis of each run to 
a common retention time axis by aligning either pairs of samples or multiple 
samples against a selected reference sample or a template.20,43 
 Alignment of total ion chromatogram curves (TIC) 
 Peak-based alignment. 
 Internal Standards as alignment reference 
Normally, referenced algorithms involve variations of Warping methods 
(COW, PTW, DTW, STW,…), which are based on the application of a non-
linear transformation to the retention time axis in order to maximize the 
correlation between the spectra20. Non-referenced or reference-free 
methods avoid the biases introduced by using reference spectra, but at a 
cost of being more computationally intensive. In these, the alignment is 
performed over all the spectra or by splitting the spectra into smaller 
segments and independently align each resulting segment.43,50 
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 Binning and clustering methods. 
 Segmenting by applying a constant shift to all spectral points. 
 
5.4.4 FEATURE CORRESPONDENCE 
In untargeted metabolomics, the term “feature” is used to describe a data 
variable that is potentially originated by a metabolite. This term is commonly 
used in MS untargeted metabolomics to refer to the m/z, or m/z-rt pairs, that 
are extracted after data processing. In other words, in metabolomics, 
features are aligned ions that are consistently detected in most samples 
meaning that they are an actual metabolite with high certainty.20 
In metabolomics, the process of grouping sample ions with similar m/z 
values that have a reproducible elution across multiple experimental runs is 
known as “correspondence determination”, an important task in order to 
supply the subsequent statistical analysis. The main difficulty within 
correspondence determination is that, even if previously aligned, m/z values 
still contain accuracy error. This is similar to the case of retention time 
alignment, the m/z variation is non-linear itself, meaning that the objective of 
correspondence is to “align” peaks across samples using both m/z and RT 
feature values, which is also generally performed with bidimensional 
warping algorithms or similar methods.51 
 
5.4.5 DATA ANALYSIS  
Data analysis in untargeted metabolomics involves the transformation and 
filtering of beforehand processed data, and it is followed by hypothesis 
testing using statistics. Given the complexity of hyphenated-MS samples, 
thousands of mz-RT features can be extracted at the end of data 
processing. However, most of them are not originated by an actual 
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metabolite due to the aforementioned reasons, in other words, during the 
preprocessing steps, there is no distinction between adduct peaks, natural 
isotopes, in-source fragments or other impurities. Therefore, careful data 
analysis is necessary to avoid misleading results.52 
Metabolomics data analysis mainly consists in the selection of a subset of 
detected features that comply within certain thresholds of variation across 
samples and minimum abundance/intensity. Additionally, before any 
statistical testing is applied, sample quantifications may be necessarily 
adjusted, which involves data normalization, scale transformation or value 
imputation if necessary.  
FEATURE FILTERING 
The following filtering strategies are applied to extract a subset of features 
that are above an acceptable intensity threshold, since MS/MS experiments 
are required in untargeted metabolomics for the ultimate step of 
identification that depends on signal intensity for reliable results. 
Additionally, low variation (CV) features are also ignored due to that they 
potentially lack biological importance.52 And finally, if isotope annotation is 
used, peaks corresponding to non-monoisotopic signals can be ruled out.  
 Intensity filter. In order to reduce the number of features that may 
be passed to statistical testing, one of the first filters involves a 
simple abundance threshold. The reason for this filter is that, since 
features of interest (i.e. statistically significant) need to be identified 
with tandem mass spectrometry, fragmented ions need to have an 
acceptable intensity otherwise the quality of fragmentation spectra 
may be compromised. Additionally, this filter serves to eliminate 
features that are close to noise level. 
 Variation filter. As mentioned above, the use of chromatography 
systems and mass-spectrometer instruments implies deviations in 
metabolite retention time and their quantification response.17,19 To 
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assess the variability of analytes, metabolomics researchers came 
up with the idea of continuously injecting identical samples in-
between other samples within the chromatographic run 25,52. These 
samples, known as quality control (QC) samples are considered 
identical to biological samples, i.e. with equivalent matrix 
composition by pooling small aliquots of all or representative 
samples of the study.25 
FEATURE ANNOTATION 
We must consider that in an untargeted metabolomics study, feature 
annotation is key because of the high redundancy of hyphenated-MS data, 
where different features may represent the same metabolite.53 In particular, 
it is important to consider that this event, called feature degeneration, is a 
natural consequence of soft ionization sources such as ESI, which increase 
the complexity of untargeted metabolomics data due to the contribution of 
isotopes, adducts and in-source fragments.54 Feature annotation is 
therefore essential to reduce false positives and to remove redundant 
information. Feature annotation leads to grouping features that originate 
from the same compound which at the same time gives valuable chemical 
information for metabolite identification.55 Isotopes can be detected in any 
type of MS method, though it mainly depends on the signal-to-noise ratio. 
Sensitivity and resolution have a great impact on the isotopic envelope of 
metabolites and adducts can increase the feature redundancy. 
The ultimate objective of most feature annotation algorithms is to detect 
features that correspond to monoisotopic peaks of frequent adducts (for 
example H or NH4 adducts), which are particularly predominant in spectral 
databases. A large collection of software to perform adduct annotation, and 
isotope annotation, in untargeted studies have been yearly developed: 
CAMERA, CliqueMS,… Their annotation algorithms normally include three 
main steps:55–59 
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 Peak grouping/clustering by: 
o Peak shape correlation. 
o Peak-abundance correlation.  
 Cluster peak annotation. 
 Neutral mass annotation.  
 
5.5 Compound identification using tandem mass spectrometry 
Feature identification is the ultimate goal in untargeted metabolomics, 
though at the same time it is the main bottleneck for definitive results. 
Feature identification consists in the identification of experimental features 
using MS/MS fragmentation in order to translate them into a molecule entity. 
Performing “a posteriori” targeted or DDA MS/MS experiments are, in 
practice, not more challenging than a full scan experiment. However, the 
interpretation of the resulting spectra is indeed challenging and, to a certain 
point, hard to reproduce/standardize.  
5.5.1 IDENTIFICATION CONFIDENCE LEVELS 
The Metabolomics Standards Initiative (MSI) was conceived in 2005. The 
early efforts of MSI were focused on community-agreed reporting standards, 
which provided a clear description of the biological system studied and all 
components of metabolomics studies.60 
The MSI Chemical Analysis working group defined four different levels of 
metabolite identification to classify the level of identification confidence in 
the literature, these four levels were later update to five by the Compound 
Identification work group of the Metabolomics Society at the 2017 annual 
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meeting of the Metabolomics Society. These include different levels of 
confidence in identification:61 
● Level 1. Valid identification. Requires the identification to be 
performed with a minimum of two independent and orthogonal 
properties, the identified compound must be compared against a 
pure reference standard under identical analytical conditions. This 
level assures unambiguous 3D structure, including full 
stereochemistry. 
● Level 2. Incomplete identification. This differs from Level 1 in the 
fact that the reference standard is not analyzed under identical 
conditions, this is the case of comparing acquired MS/MS spectra 
against an equivalent found in spectral databases. This level at least 
confirms 2D structure. 
● Level 3. Putative identification. Identifications at this level are not 
confident enough to supply a metabolite identity but may supply 
information about the formula and compound subclass or family, for 
example in the case of lipids, phosphatidyl-choline family. This level 
has some certainty about compound formula and part of its 
structure. 
● Level 4. Molecular formula annotation. Possibly accompanied by 
adduct and charge information. These arise when accurate mass 
and isotopic distribution patterns produce tentative structures from 
database searches. Note, a single molecular formula typically 
renders multiple candidate structures. 
● Level 5. Unknown compound. Completely unidentifiable features, 
whose MSMS spectra or formula are impossible to annotate. 
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5.5.2 GC-EI-MS IDENTIFICATION 
In most GC/MS metabolomics experiments, EI-MS setting 70 eV as 
ionization energy and in positive ionization detection mode is used as a 
universal ion source. These fragmentation patterns are highly reproducible 
not only in m/z values but also their relative abundance, which increases the 
accuracy and reliability of the peak assignment by comparison with spectral 
libraries.39,40   
The community-standard workflow for GC/MS metabolite profiling typically 
implies working with deconvoluted mass spectra and identified compounds 
instead of unidentified peaks, although an unbiased approach based on 
peak picking followed by manual spectra revision is also acceptable, yet 
identification then becomes a harder task and normally relies on manual 
revision of the raw spectra. 
A further level of effort for powerful identification results involves the use of 
retention indices (RIs) based on aliphatic carbon numbers by Kovats, that 
consists in a standardized collection of alkanes that are injected and thus 
their retention time used as a reference to normalize the adjacently eluting 
alkanes. Kovats RIs have been progressively included in mass spectral 
databases commonly used for GC/MS metabolomics. In combination with EI 
spectral matching, RI significantly improves metabolite annotation.62 
Independently of the approach used for data processing, the spectra 
databases commonly used in GC/MS-based metabolomics are NIST 
(http://www.nist.gov/srd/nist1a.cfm), the Golm Metabolome Database (GMD, 
http://gmd.mpimp-golm.mpg.de), and the Fiehn BinBase library (http:// 
fiehnlab.ucdavis.edu/db), which contain mainly TMS-derivatized 
metabolites. In addition, HMDB, MassBank and the Madison Metabolomics 
Consortium Database (MMCD) also contain EI spectra and RI data.62 
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5.5.3 IDENTIFICATION IN LC/MS METABOLOMICS 
Ideally, the identification procedure involves the comparison against an 
MS/MS spectrum of a pure compound corresponding to the expected 
metabolite hit, so-called compound reference spectrum. However, in 
practice, levels 2 and 3 are the most commonly reported since level 1 is out 
of financial reach for the majority of research groups. In general, 
experimental MS/MS data is searched against a reference MS/MS 
database, if a definitive match, this is the most conclusive evidence for 
validating the identification of a metabolite feature using MS/MS62. However, 
prior to MS/MS comparison, a few considerations must be taken when 
checking whether the experimental MS/MS spectra match that of a 
reference spectrum found in compound spectral databases. Different criteria 
of the acquisition methods must be taken into account to consider whether a 
pair of MS/MS spectra are comparable:8 
● Acquisition instrument type. QqQ, QTOF, ion trap and Orbitrap 
produce different fragmentation patterns.  
● Mass accuracy. This affects the precursor ion as well as its 
fragments, and it depends on the instrument setup used to obtain 
both the experimental and reference spectrum. 
● Ionization mode and energy. Polarity, fragmentation method (CID, 
HCD) and energy used have an impact on MS/MS fragmentation 
patterns. 
● Adduct of the precursor ion. Proton adducts overpopulate MS/MS 
spectra databases but depending on chromatographic conditions 
other adducts may be detected (+NH4 or +Na)40. Plus, some 
metabolite families are prone to prefer non-proton adducts. 
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Table 3. Metabolomics databases for identification. Extracted and 
adapted from Kind et al.8 
Name 
Number 
of 
MS/MS 
spectra 
Number of 
compounds 
Available 
online 
Freely 
available 
Instru-
ment 
diversity 
NIST14 
MS/ MS 
193,120 9,344   +++ 
METLIN 2019 
> 
440,000 
>22,000 +  +++ 
LipidBlast 212,516 119,200   + 
MoNA 194,000 68,700 + + +++ 
mzCloud 
(Thermo 
Scientific) 
182,000 2,800 +  + 
MetaboBASE 
(Bruker) 
26,000 13,000   + 
GNPS 212,230 12,694 + + ++ 
ReSpect 9,000 4,000 + + + 
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MSforID 20,000 1,200   + 
HMDB 
 
22,198 114,008 + + ++ 
NIST17 
MS/MS 
574,826 13,808   +++ 
 
5.5.4 AUTOMATIZING METABOLITE IDENTIFICATION 
AUTOMATIC IDENTIFICATION  
The validation of fragmentation spectra, which relates to both EI and MS/MS 
spectra, has been traditionally performed in a manual manner by 
experienced structural elucidation analysts. In summary, a positive 
identification depends on the similarity of the fragmentation patterns when 
comparing the reference and the experimental spectra, thus confirming the 
source of the detected fragments and explaining their relative abundance.61 
However, given the new capabilities of DDA systems, it is now possible to 
obtain hundreds of MSMS spectra in a single experimental run, meaning 
that the process of metabolite identification must be necessarily 
automatized. Automatic identification tools have been lately developed to 
speed metabolite identification by applying computational power. As 
mentioned above, they may start by filtering some candidates from a 
reference, or library, spectra that could match the conditions of the 
experimental challenge, basically based on mass accuracy and ionization 
parameters. Algorithms must take into account that experimental spectra 
may contain noise and impurities, therefore it is necessary that they 
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unbiasedly calculate the magnitude of similarity between the experimental 
and reference spectra. 
Fragmentation spectra comparison is achieved by using different score-
based metrics that are typically calculated considering m/z-relative intensity 
pairs of the experimental spectrum and library spectra as well as additional 
parameters such as weighting functions:8 probability match algorithm, 
Dotproduct, Jaccard index, Pearson similarity, Jeffries-Matusita distance, or 
random projection, to name a few. 
Additionally, spectral databases are limited, and thus sometimes no 
reference spectrum is found for an experimental challenge. Then, even an 
experimented chemist would struggle to extract a compound identification 
by elucidating the spectra based on experience and chemical knowledge 
itself. 
IN SILICO MS/MS 
In order to overcome the challenge of underpopulated spectra62, a few 
alternative computational tools have been designed to predict the MS/MS 
spectrum given a compound structure, known as “in silico” MS/MS spectra 
generation.  
First, molecular structures need to be transformed into a computer readable 
format that codes its atoms and bonds into a string, nowadays InChI (and 
InChIKey) is the most used, followed by the older SMILES. These coded 
chemical structures are available on most spectral databases.61 In silico 
MS/MS spectra generation is a daunting task and prone to miscalculations. 
Four general methods can be distinguished when generating spectra “in 
silico”, which can be based on:63 
● Quantum chemistry. Uses chemistry principles, but takes longer 
computing. 
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● Machine learning. Requires diverse training sets but results are 
quick. 
● Heuristic algorithms. Limited to certain compound classes, 
generally rule based. 
● Reaction chemistry. Based on metabolic reaction pathways, but 
does not calculate relative fragment intensities. 
 
Table 4. Bioinformatic tools for MS/MS “in silico” identification. 
Adapted and extended from Blaženović et al.61 
Name Fragmentation method 
MS-FINDER 
Rule-based + Quantum 
chemistry 
CFM-ID 
Rule-based + Machine 
Learning 
MetFrag Rule-based 
ChemDistiller 
Machine Learning + 
Quantum chemistry 
MAGMa Rule - based 
CSI-FingerID 
Machine Learning + 
Quantum chemistry 
iMet 
Reaction chemistry + 
Machine learning 
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6. METABOLIC NETWORKS 
6.1 Networks and graph science 
The history of graph theory started in 1736 with the work of the 
mathematician Leonhard Euler. Graphs are mathematical structures, 
matrices, used to model pairwise relations between objects. Formally a 
graph is a symmetric matrix that defines the connections, known as edges 
or links, between a set of nodes, vertices or points. There are two types of 
links: directed (unidirectional) or undirected (bidirectional). In many physical 
applications it is desired that the edges of the graphs support some weights, 
i.e., real numbers indicating a specific property of the edge. Much later, the 
term “network” has become a synonym for “graph” in real-world applications 
of graph science. Graphs are used in different fields of science, for example 
in quantum physics, statistical physics, electronic systems, oscillation 
mathematics,… 
Complex networks are graph models used to model real world systems, 
they can be considered as the schematic representation of organized 
systems in a variety of scenarios, ranging from social and technological to 
biological and ecological systems, interaction networks or social networks. 
Examples of complex networks are: metabolic networks, trade networks, 
protein-protein interaction networks. Their study has become a major field of 
interdisciplinary research in which mathematicians and physicists have 
significantly contributed by creating new algorithms to the study of 
topological and dynamical properties of complex networks.   
 
6.2 Networks in biology 
The combination of omics high-throughput technologies has enabled the 
coordinated study of cellular components at the level of genes, proteins, 
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metabolites, and molecular interactions that occur between them. These 
studies have resulted in the generation of large-scale datasets that have 
served as the foundation for the modelling/construction/scaffold of 
metabolic, regulatory, signaling, and protein-protein interaction networks.64  
Network science has suggested that biological networks have two distinct 
structural properties. First, it has been shown that several of these networks 
are scale-free (most nodes have more connections than average) and they 
possess a “small world” property (most nodes can be easily interconnected -
through other edges- even if they are not directly connected). Second, 
scale-free networks are suggested to have high error tolerance (tolerance 
against random failure, robustness to random node removal) and low attack 
tolerance (vulnerability to the failure/removal of the highly connected 
nodes).64 In short, this indicates that the connections in biological networks 
are organized in a way that there is a high connectivity between most 
neighbors and that even if they can be structured into subnetworks, the 
removal of a single node can be circumvented through another path.65 
In general, these types of networks can be classified on the basis of the 
nature of the interaction into two broad categories:64  
● Influence networks, where the nature of links represent whether an 
interaction is present or not, or the type of interaction, such as in 
protein-protein interaction or signaling networks. 
● Flow networks, where a specific variable such as mass or energy 
flow may be conserved at each node, such as metabolic networks. 
In the context of biological networks, a metabolic network is a flow network 
that contains the information of how an organism converts carbon and 
energy sources using electron donors and acceptors in order to generate 
biomass, energy, and byproducts.66 
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6.3 Genome-scale metabolic networks 
Metabolic networks can be built from different sources of information, the 
most comprehensive examples are genome-scale reconstructions, 
knowledge-based models built by a team of experts using information from 
gene sequencing experiments, that record a collection of metabolic 
reactions within a biological system. 
Genome-scale metabolic models (GMM) are highly detailed data structures 
that can be used to build metabolic networks that contain known or 
predicted metabolic reactions in an organism and can therefore serve as 
functional databases of cell-specific metabolism. Most genome-scale 
models are annotated with curated gene-protein-reaction associations 
linking genes with enzymes. These gene–protein-reaction associations are 
formulated as boolean rules considering isozymes and subunits of protein 
complexes.67 In short, GMM can be used to construct metabolic networks 
containing fine annotation about gene expression, enzyme kinetics and 
metabolic pathway connection.  
The process of building a GMM is a laborious task, which involves iterative 
series of manual curation and database searching, the latter may be 
programmatically optimized for time saving.68 First, a draft reconstruction is 
generated starting from the genome and including all the genome-encoded 
metabolic reactions of the targeted organism. The draft reconstruction also 
includes annotated enzyme, reaction, and pathway data from databases like 
KEGG69, BioCyc70, and BRENDA71 that serve as sources of the GPR 
rules.67  
The earlier GMM were built for microorganisms such as E.Coli. But later, 
reconstructions of human metabolism were attempted after the publication 
of the complete human genome sequences in 2004, which required a much 
larger number of pathways. HumanCyc (in 2004) and Reactome 
knowledgebase (in 2005) were the first successful attempts to build a 
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curated collection of biochemical reactions in human cells. Later, the first 
models of human metabolism were published in 2007, these were Recon 1 
and EHMN (Edinburgh human metabolic network) reconstructions. 
Importantly, the sequence of manual curation steps is needed to improve 
the draft reconstruction, by periodically gathering evidence to prove or 
disprove the presence of a reaction in the network of the organism. 
Maintaining models up-to-date improves predictability by expanding and 
correcting the network content based on emerging biochemical knowledge. 
Later, in 2013, a large improvement of the number of metabolic processes 
was achieved with an updated version of Recon: Recon 2, a consensus 
model that includes all reactions from an updated version of EHMN, Recon 
1, HepatoNet1, and a module for acylcarnitine and fatty-acid oxidation. The 
following years, Recon2 evolved into the version Recon 2.2 with improved 
reaction balances and updated gene-reaction associations.72 
Simultaneously, a larger reconstruction named HMR (Human Metabolic 
Reaction database) was built independently, based on HepatoNet1, 
Recon1, EHMN, Reactome, HumanCyc, KEGG and the Human Metabolic 
Atlas. HMR was then extended in 2014 to include lipid metabolism, 
therefore generating HMR2.  
Later, in 2017, a new human metabolic model named iHsa was obtained as 
an expanded and better curated version of HMR2.67 Recently, Recon 3D 
appeared as a result of incorporating HMR2 into Recon 2 together with a 
number of additional reaction sets, including reactions modelling host-
microbe interaction, reactions for simulating drug effects on human 
metabolism, reactions for absorption of dietary compounds, reactions of lipid 
metabolism and reactions from metabolomics datasets. 3D protein 
structures, pharmacogenomics data and atom-atom mappings were also 
included in the model.67  
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Table 5. Genome-scale metabolic models. Extracted from Angione 
et al.67 
Model Genes Metabolites Reactions GPR rules 
HumanCyc 3209 1761 1716 - 
Reactome 1180 1131 1216 - 
EHMN 2492 3695 6216 - 
Recon 1 1905 2766 3744 2307 
HMR 3668 6000 8100 6015 
Recon 2 2140 5063 7440 4821 
HMR2 3765 6006 8181 6071 
Recon 2.2 1675 5324 7785 4742 
iHSA 2315 5620 8264 5961 
Recon 3D 2248 5835 10600 5938 
 
The fields of science in which metabolic networks can be applied are 
diverse: 
 Contextualization of high-throughput data. By serving as a 
framework on which other omics data can be overlaid/mapped for 
contextualizing high-throughput data and aiding profiling 
approaches. However, a major challenge still lies in determining an 
optimal strategy for interpreting the annotated data. 
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 Guidance of metabolic engineering. Traditionally, metabolic 
engineering has been performed on a small scale through 
manipulation of a few genes to affect the yield of a target metabolite, 
in which enzyme modification is directed based on local metabolic 
knowledge. The inherent drawbacks of using local analysis tools to 
guide cell-scale metabolic engineering efforts have motivated the use 
of metabolic networks, bringing up the field of ‘systems metabolic 
engineering'.    
 
 Directing hypothesis-driven discovery. Metabolic networks 
represent summarized collection of previously confirmed 
hypotheses; therefore, they are ideal for the construction of new 
hypotheses.  Metabolic networks have been used to frame 
investigations into specific biological questions, using a mix of 
traditional biological approaches and computational systems-level 
thinking, they enable systematic hypothesis testing and prediction. 
 
 Interrogation of multi-species relationships. Metagenomics 
studies particularly have shown most ecosystems to be extremely 
diverse, while higher-eukaryotic biology requires the study of multi-
cellular systems. Lately, an increasing effort has been put into 
modelling such interactions in metabolic network models.  
 
 Network property discovery. Biological networks are the ultimate 
representation of scientific holistic thinking, to be able to detect 
molecular events or phenomena that would be undetectable by 
reductionist approaches. GMM have enabled analysis of whole 
networks rather than individual pathways or genes, and many 
computational techniques have been developed to probe network 
properties.  
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The field of computational systems biology has produced a rich array 
of methods for network-based analysis, but many of these methods 
produce results that can be difficult to link to observable phenotypes.  
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7. TRACING METABOLISM USING 
STABLE ISOTOPES 
7.1 Stable isotopes 
Stable isotopes such as 13C or 15N, have the same number of electrons 
and protons and consequently share the same physicochemical properties, 
yet they differ in mass due to a different number of neutrons. Among 
biochemically relevant elements, carbon, hydrogen, nitrogen, oxygen and 
sulfur all have one or more stable isotopes with measurable abundance in 
nature.53 Isotopologues, that is metabolites containing stable isotopes and 
their unlabelled counterparts, have the same chemical formula and structure 
and hence generally behave identically during chromatographic 
separation.53 
The ability to discover new metabolic pathways by following the distribution 
of heavy atoms in isotopologues through the metabolic network was 
exploited during the classical period of biochemical pathway identification, 
which are the basis of current isotope labelling or isotope tracing methods. 
During its roots these studies were mostly performed using radioactive 
isotopes even though they are hazardous, while stable isotopes are not.53 
With the advent of high sensitivity MS instruments and the chemical 
synthesis of stable isotope enriched compounds, radioactive isotopes were 
retired by these novel and lesser dangerous homologues.    
 
7.2 Stable isotope labelling 
The major interest in stable isotope labelling for metabolomics stems from 
its ability to aid in the measurement of dynamic activity of metabolic 
pathways, in order to provide mechanistic explanations for the perturbations 
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in metabolite levels observed in classical metabolomics studies. Stable 
isotope labelled precursors with uniform or positional labelling of constituent 
atoms have been used to generate biological samples that allow the study 
of their metabolic fate throughout the metabolism in an untargeted way. 
Similar tracer analyses have also been used for many years alongside 
metabolomics studies to study specific metabolic pathways of interest in a 
targeted manner.73 In the context of systems biology, SIL provides an 
opportunity for reconstructing and validating both stoichiometric and 
dynamic computational models. 
 
Figure 5. Stable isotope labelling. 
Software solutions to routinely extract isotopologue abundances on a large 
scale are available. Biochemical interpretation of these data still requires a 
significant level of manual curation, but the growing availability of atom-
resolved metabolic networks, where the source of specific atoms in each 
molecule can be traced from precursor substrates, offers the potential for 
computational approaches to biological inference and hypothesis generation 
based on network-wide isotope-labelled metabolomics data.53 
Apart from the choice of detection platform and separation methods, stable 
isotope labelling metabolomics requires a few extra considerations given its 
particularities: 
● The selection of labelled nutrient, also called tracer metabolite, 
depends on the study hypothesis and the known metabolic pathways 
in the organism of interest.   
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For example, hypothesis-free metabolomics studies that require 
extensive metabolite labelling utilize fully labelled carbon sources, 
such as U-13C-glucose. Other common stable isotope tracers 
include: U-13C-glutamine to measure TCA cycle anaplerosis, U-
13C, 15N-glutamine to detect pathways for carbon and nitrogen 
assimilation, or 13C-bicarbonate to monitor CO2 incorporation from 
the atmosphere in the case of autotrophs, such as plants.74 
● The kinetics of nutrient assimilation differ from system to system, an 
utterly important consideration in steady-state labelling studies. 
Systems must be characterized in order to assure that isotopologues 
reach a concentration high enough to be detectable in the 
quantification platform used. In particular, in the case of secondary 
metabolites and many macromolecules which need a significant 
higher culturing time with labelled nutrients, while labelling of central 
carbon metabolites may occur within seconds.74,75  
 
7.3 Qualitative assessment of metabolic fluxes 
Stable isotope tracing experiments can be used to follow the fate of atoms 
from a substrate downstream into biochemical reactions. Analysis of steady-
state labelling patterns in downstream metabolites provides information as 
to their origin and rates of production. By computing fractional enrichments 
using stable isotope tracing experiments, a series of qualitative or 
semiquantitative flux predictions around each analyzed metabolites can be 
obtained. Of mention, direct interpretation of data from stable isotope tracing 
experiments cannot be used to quantify network-wide flux analysis. This 
approach stops short of modeling network-wide flux maps. However, it is 
relatively straightforward and has become increasingly accessible due to the 
widespread adoption of high-resolution mass spectrometers.76,77   
 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
INTRODUCTION 
97 
 
7.4 Quantitative assessment of metabolic fluxes 
Fluxomics is an interdisciplinary science that aims to quantitatively 
determine the turnover of metabolites through a network of enzymatic 
reactions (metabolic flux). Fluxomics integrates experimental measurements 
of metabolic fluxes with mathematical models to determine the absolute flux 
through the metabolic network.78 Metabolic fluxes are governed by the 
interplay of gene expression, protein concentration, protein kinetics, 
regulation, metabolite concentration and thermodynamic driving forces. 
These metabolic fluxes are the central trait of cellular metabolism 
representing its integrated functional output response and consequently 
becoming the best signature of the cellular phenotype.79 However, 
metabolic fluxes cannot be directly determined from other -omics data.  
Zamboni et al.80 nicely illustrates this concept by comparing flux to traffic. 
Traffic, regarded as the mobility response within a city, results from the 
relationship among parking lots (mRNAs), roads (proteins), and cars 
(metabolites). 
However, knowing the number of parking lots, roads and cars is not enough 
to inform on traffic (i.e., knowing whether cars are stalled or allowed to freely 
move). Similarly, quantifying molecular levels of mRNA, proteins and 
metabolites using -omics technologies does not provide a measurement of 
the metabolic fluxes. In fact, metabolic fluxes cannot be directly measured 
but need to be inferred from other observables.74 They are usually 
estimated through mathematical modeling of metabolic reactions. In general 
terms, this modeling uses genome-scale metabolic reconstructions and 
linear programming to quantitatively estimate distributions of metabolic 
fluxes. Metabolic reactions enclosed in the reconstruction are formalized to 
a set of mass balance equations resulting from a matrix representation of 
the stoichiometric coefficients of the metabolites participating in each 
reaction. Assuming steady-state conditions, linear programming can be 
applied to compute a vector of quantitative fluxes that maximize a 
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predefined objective function and solves this set of mass balance 
equations.76 This model-based quantitative estimation of metabolic fluxes is 
challenging, particularly for large reconstruction models holding a far large 
number of reactions than metabolites. In such cases there is more than one 
solution to mass balance equations and quantitative fluxes remain 
undetermined. Here, experimental constraints other than steady-state mass 
balance assumption are of great help to find the range of feasible fluxes 
across a metabolic network (i.e., metabolites uptake/secretion rates 
determined from medium measurements). 
Depending on the optimized objective function we can distinguish two main 
model-based approaches to quantify metabolic fluxes:  Flux Balance 
Analysis (FBA) and 13C Metabolic Flux Analysis (13C MFA).76,78,79 Both use 
stoichiometric, thermodynamic and experimental constraints to find the 
range of feasible fluxes across a metabolic network and then find the flux 
distributions within that space that optimize a given objective function. In the 
case of 13C-MFA this objective function is set to minimize the difference 
between simulated and experimentally measured 13C enrichment in 
metabolites whereas the objective function definition for FBA is not that 
clear, particularly in FBA-biomedical applications.81 Nowadays, 13C 
metabolic flux analysis (13C-MFA) is the predominant technique used for 
quantitatively estimate intracellular fluxes.82 
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This thesis is mainly aimed at developing experimental and computational 
methods to predict and detect a profile of metabolites with imbalanced 
fluxes/abundances in a cellular phenotype.  To accomplish this, three main 
sub-objectives have been established: 
 To develop a computational framework to infer metabolic 
imbalanced fluxes/abundances from quantitative proteomics data.   
 To establish a targeted methodology for high-throughput metabolite 
flux determination of central carbon metabolism pathways by using 
stable isotope labelling experiments. 
 To develop a method aimed  to assess  metabolic fluxes beyond 
central carbon metabolism pathways by unbiased detection of  
fractional isotopologue enrichment in stable isotope labelling 
experiments.  
 
This thesis is conformed by three chapters each one covering one of the 
individual sub-objectives described above. In Chapter 1 a novel data 
analysis approach is developed to predict a set of metabolites with 
imbalanced fluxes/abundances from quantitative proteomics experiments. 
This approach is based upon statistical inference on quantitative proteomic 
data considering the connectivity of the metabolic network resulting from 
tailoring a genome-scale human reconstruction model using detected 
enzymatic proteins. To further confirm predicted imbalanced fluxes, we have 
developed a series of methodologies to experimentally measure them in a 
high-throughput manner.  Thus, in Chapter 2, a singular and unique method 
directed towards the qualitative assessment of flux profile in central carbon 
metabolism pathways is developed. This is done by measuring  how the 
label of an enriched substrate propagates through the metabolite 
intermediates in such pathways. Finally, a method expanding the coverage 
of the empirical assays of metabolic flux profiles beyond central  carbon 
metabolism is presented in Chapter 3.  
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CHAPTER 1. Inferring metabolite 
alterations within metabolic 
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1.1 Introduction 
Proteins are the key components for the three main categories of biological 
networks, the most common being protein–protein interaction networks, 
signaling networks, and metabolic networks. Proteomics endeavors to study 
protein levels, post-translational modifications and protein-protein 
interactions, which is subsequently used to understand cellular processes, 
including metabolic regulation. Proteins have different roles in metabolism; 
proteins with enzymatic activity can control metabolite concentrations and 
metabolic fluxes, and non-enzymatic proteins can mediate the uptake and 
transport of metabolites, or activate/deactivate signaling cascades in 
metabolic regulation. Defects on protein expression levels have been 
thoroughly reported as the cause of multiple diseases and have become the 
spotlight for many researchers in the fields of molecular and systems 
biology.1–4 
Typically, transcript abundances have been used as a surrogate for protein 
measurements to study metabolism, however with the improvement of 
proteomic technologies and analytical approaches over the last decade, the 
sensitivity and the range of proteins quantified have increased dramatically 
which has also expanded the landscape of enzymatic proteins in proteomic 
datasets.5 Similarly, metabolomics attempts to accurately measure the 
abundance of metabolites as a readout of the metabolic activity and 
physiological state of a cell.6 Together, these omic sciences can provide 
profound knowledge on the metabolic regulation and metabolic rewiring of 
cells under different environmental stimuli. 
Genome-scale metabolic models computationally describe gene-protein-
reaction associations for entire metabolic genes in an organism, and can be 
used to predict metabolic fluxes for various systems-level metabolic studies. 
A well-known example of a metabolic model is Recon 27 an expansion of 
Recon 1, the earliest comprehensive human genome-scale metabolic 
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reconstruction built by a community of experts in the computational 
modelling area. Recon models were created to provide computational 
scientists with a peer-reviewed resource to elucidate and understand 
genotype–phenotype relationships in metabolism. Recon2 contains itemized 
information of metabolites and metabolic reactions, annotated with gene 
associations and organelle localization. It is possible to extend it further with 
information on gene-protein linkage from other databases such as KEGG8 
or REACTOME9. Genome-scale metabolic models can be used to build 
metabolic networks, or graphs, which are node-link representations using 
the connectivity between metabolites based on the reactions in which they 
take part. The topology of biochemical networks, including protein–protein 
interaction networks, signaling networks, and metabolic networks, with 
transcriptomic and proteomic data can be used to predict the impact of 
perturbation patterns in the absence of the kinetic parameters.10 These 
studies have revealed the interconnectivity of genes and proteins, and the 
presence of functional modules where gene and protein expression are 
coordinated.11.  
This knowledge is still not systematically implemented as a framework to 
interrogate metabolism, on the contrary, proteins are statistically treated as 
if they functioned independently (see Figure 6).  
Herein, a data analysis workflow that employs the connectivity of a 
metabolic network, based on the Recon 2 structure, is presented to 
unbiasedly test metabolites within the network by evaluating the level of 
proteins associated with their transformation as a whole, instead of 
separately.  
To develop and validate this novel analysis we obtained both proteomics 
and metabolomics data from ARPE-19 cells, an in vitro cellular model of the 
retinal pigmentary epithelium; and human vitreous humor samples from 28 
individuals at different stages of DR phenotype/disease (13 non-diabetic 
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patients, 4 non-proliferative diabetic patients and 11 proliferative diabetic 
patients).  
 
Figure 6. Conventional proteome analysis. Differentially expressed 
proteins are identified by using a statistical test (e.g., t test analysis 
with Bonferroni correction), followed by annotation (e.g., pathway) 
enrichment analysis. 
Diabetic retinopathy is a common long-term diabetes complication occurring 
to type II diabetes patients that leads to vision impairment or blindness. 
Most of the research on the pathogenesis of DR has been focused on the 
impairment of the neuroretina and the breakdown of the inner BRB. 
However, the effects of diabetes on the retinal pigment epithelium (RPE) 
have received less attention. RPE is a monolayer of pigmented cells 
situated between the neuroretina and choroids. RPE constitutes the outer 
BRB and is essential for neuroretina survival, and consequently, for visual 
function290. The specific functions of RPE are the following: i) transport of 
nutrients, ions, and water; ii) absorption of light and protection against 
photo-oxidation; iii) re-isomerization of all-trans-retinal into 11-cis-retinal, 
which is a key element of the visual cycle; iv) phagocytosis of shed 
photoreceptor membranes; and v) secretion of various essential factors for 
the structural integrity of the retina.12 Therefore, the study of RPE is 
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fundamental to gain new insights into the mechanisms that lead to DR and 
to identify new therapeutic targets for this devastating complication of 
diabetes. 
 1.2 Methods 
In order to build the reaction-based metabolic network and annotate each 
reaction with Uniprot accession identifiers it is important to consider the 
internal organization of the used database. In here we parsed and built an 
annotated metabolic network for two different well-known databases: KEGG 
and Recon 2. The main difference between KEGG and Recon databases is 
that, in the latter some genes are annotated as gene clusters in the form of 
gene-protein-reaction rules (GPRs).  
Our aim is to generate a comprehensive metabolic network but with low 
redundancy, so it only does contain indispensable edges, and relate them to 
a series of genes and protein identifiers. In Figure 7 we show how this is 
achieved in RECON and KEGG for a well-characterized enzymatic reaction 
(Lactate dehydrogenase, EC 1.1.1.27), displaying the singularities of each 
database: 
 In the case of Recon SBML files, the XML structure contains two 
main lists of elements: a list of reactions that in turn contains 
information about associated modifiers - genes -, reactants and 
products - metabolites- ; and a list of species, in other words, entities 
that participate in reactions, metabolite lists that collect metadata 
such as formula or name, and modifiers, which are combinations of 
one or more genes that code for proteins that perform such reaction 
(GPRs), Uniprot identifiers are included in the metadata of each 
modifier. Using this information, we built a metabolic network 
characterized by 2642 nodes (metabolites) and  11894 edges (4302 
reactions), with a total of 2598 Uniprot identifiers associated to them. 
However, we decided to ignore some ubiquitous and non-informative 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
RESULTS 
117 
 
metabolites (a total of 35, such as H2O, H+, …) and transport 
reactions (reactions that do not alter metabolite abundance),  
reducing the complexity of the network. 
 
 In the case of KEGG, we parsed different files from the FTP 
downloadable database. The reaction file contains information about 
reactions, importantly reactant pairs and enzyme code annotation of 
each reaction. Reactant pairs relate metabolites that are transformed 
into one another in a reaction, in addition, they can be distinguished 
with different subtypes  (main, cofac, ligase and leave). Using other 
files found in the database (hsa_enzyme.list and hsa_Uniprot.list) it 
is possible to relate each enzyme code to a list of individual gene(s) 
that in turn can be linked to their coded Uniprot identifiers. To build 
the KEGG metabolic network, we used only main reaction pairs, as 
other reactions normally involve less relevant metabolic 
transformations. This resulted in 7181 nodes (metabolites) and 
12641 edges (9028 reactions), with a total of 3596 Uniprot identifiers 
associated to them. 
Once the scaffold metabolic networks are built, they must be adapted to 
proteomics data. Since protein expression depends on multiple factors and 
proteomics is generally not sensitive enough for a full coverage of our 
database, metabolic networks must be subset based on detected proteins. 
In here, the Recon metabolic network is filtered based on its GPRs, 
meaning that a reaction is present if at least a full modifier (gene-protein set) 
is annotated, thus a protein is detected per each gene according to the logic 
of the GPRs, in Figure 7 modifiers translation into gene and protein entities 
is shown in the dashed square.  While, in the case of KEGG, which lacks 
GPRs, a reaction is used if at least a protein of one of the related genes is 
found in the proteomics dataset. Therefore, for the exact same proteomics 
dataset, KEGG is prone to have a higher number of metabolic reactions in 
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the network than that of Recon. In both databases, we tested building of 
networks enforcing the detection of a protein per associated gene, such 
approach led to poor results leading to a high proportion of disconnected 
nodes.  
 
Figure 7. Extraction of reaction, reactants and their associated 
genes and proteins for Recon 2 SBML and KEGG databases. 
Even though, apparently the results seem to indicate that KEGG generates 
a larger network, we found that a large proportion of nodes are actually 
disconnected, which also occurs in the case of Recon but is less dramatic. 
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The overlap in terms of protein identifiers included 1894 Uniprot identifiers, 
about 55-60%.  
In addition, we saw that in the case of Recon, we retained a larger 
proportion of its reaction collection (Figure 8). Namely, out of the total of 
7440 reactions found in Recon 2, 3286 can be linked to at least one protein 
and gene identifier, while for KEGG the proportion was limited to 2181 out of 
7876 (2181+5695) reactions. Even if KEGG contains a larger collection of 
enzymatic reactions (reactions annotated with an EC code): 8520 
(5695+644+2181) to 4302 (3286+1016). 
 
 
Figure 8. Venn diagrams depicting the result of reaction filtering 
for metabolic network building in KEGG and Recon 2. Note: In the 
case of Recon, reaction localization was ignored. 
1.3 Results  
Regulatory mechanisms in response to mutations, environmental insults or 
perturbations may cause changes in the cell's metabolic profile, leading to 
the accumulation of some metabolites and an increased (or decreased) flux 
through certain metabolic pathways. When this takes place in the context of 
a pathological state, these changes are referred to as the disease-
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
RESULTS 
120 
 
associated phenotype. In consequence, the characterization of the 
phenotype-associated metabolic profile is key to understanding, early 
diagnosing or even treating some diseases. 
Recon 2 builds into a manually curated metabolic network, which can be 
enriched with gene-protein annotations, and protein identifiers linked to the 
corresponding Recon reactions (Figure 9). Extending Recon 2 annotation 
with associated proteins yields a new layer of useful data for metabolism 
interrogation and network perturbations. Here we used a database (SBML 
format) of 7.440 reactions, 2.642 metabolites and 3.656 associated genes. 
Using the metabolic network linkage (Figure 10 A), we explored the number 
of associated proteins per metabolite, namely proteins that participate in the 
reactions that consume or produce a given metabolite (Figure 10 B), 
revealing that about 40% of metabolites are potentially regulated by more 
than 10 enzymes. 
 
Figure 9. SBML files from Recon 2. Containing human gene-protein-
reaction associations: 7.440 reactions including 3.656 genes, 3.090 
protein (Uniprot) identifiers and 2.642 associated metabolites. Finally, 
there are 2.598 proteins associated to metabolic reactions that 
regulate 1.705 metabolites. 
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Figure 10. Recon metabolic networks. (A, top) In a reaction-based 
network, substrates and products are connected by one edge 
indicating the metabolic reaction between the metabolites (nodes). In 
an enzyme-based network, edges are all possible proteins with 
enzymatic activity catalyzing the interconversion of depicted 
metabolites (nodes). (B, bottom) Bar plot representing the number of 
proteins (enzymes) involved in metabolic reaction for every 
metabolite. 
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Next, we investigated the coverage of our TMT-based quantitative 
proteomics analysis of ARPE-19 cells exposed to 5mM glucose and 
normoxia (N5), 25mM glucose and normoxia (N25), 5mM glucose and 
hypoxia (H5), or 25mM glucose and hypoxia (H25) in the Recon 2 Out of 
5,419 identified proteins, 1,099 (20%) were proteins with enzymatic activity. 
Of these, 718 were quantified in all four experimental conditions and the 
three biological replicates. Subsequent analyses were performed on this 
subset (Figure 11). 
 
Figure 11. Summary of the quantitative proteomic analysis on 
RPE cells. The venn diagram shows the overlap between all reactions 
in Recon2 with Uniprot ID (4.816 in total), the enzymatic reactions 
(3.330 reactions) and finally, enzymatic reactions found in ARPE cells 
(1.766 reactions). 
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The 718 enzymes expressed in ARPE-19 cells were associated with 
metabolites based on the reactions they are involved in Recon 2. For most 
metabolites the number of proteins was large enough to generate a 
distribution of values (Figure 12A), so a binomial test could be applied to 
calculate if that distribution is equally centered around the non-change, 
meaning that the null hypothesis considers that the values are evenly 
distributed (Figure 12B). The binomial test was performed for each 
metabolite in the metabolic network, and those metabolites with a significant 
p-value, that is, whose distribution of protein abundance (fold-change) is 
different from control (N5), were considered altered metabolites. 
Based on the 3,259 proteins, a total of 1,766 reactions were filtered out of 
the 4,320 Recon 2 non-transport reactions, resulting in mapping 1,390 
metabolites out of the 2,000 found in Recon 2. Out of these, 162 were found 
to be significant after binomial testing based on the proteins associated to 
them. Most of the 127 metabolites (~ 78%) were lipids, and the rest were 
associated with amino acid and nucleotide metabolism, one carbon 
metabolism, glutathione metabolism or pentose phosphate pathway among 
others, as reported in Table 6 (pathway enrichment analysis using IMPALA). 
  
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
RESULTS 
124 
 
A) 
 
B) 
 
Figure 12. Interrogating the metabolic network with proteomics. 
(A) Bar plot representing the number of detected and quantified 
proteins (enzymes) in ARPE-19 involved in metabolic reaction for 
every metabolite reported in Recon 2. (B) Information from the 
enzyme-based network is used to statistically test the collective 
abundance of all the experimentally detected enzymes associated 
with every metabolite under different experimental conditions relative 
to a control.  
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Table 6. Pathway enrichment analysis from IMPALA. 
Pathway P-value Q-value 
Fatty acid triacylglycerol and ketone body 
metabolism 
7.53E-17 2.69E-13 
Fatty Acid Beta Oxidation 5.15E-09 7.66E-07 
Metabolism of amino acids and derivatives 8.84E-05 0.00631 
Metabolism of nucleotides 0.000209 0.013 
Pentose Phosphate Pathway 0.000381 0.0216 
Methylation Pathways 0.000785 0.0301 
Trans-sulfuration and one carbon metabolism 0.00139 0.034 
Alpha-linolenic (omega3) and linoleic (omega6) 
acid metabolism 
0.0016 0.0371 
Trans-sulfuration pathway 0.00188 0.0371 
Glucuronidation 0.00255 0.0457 
Asparagine N-linked glycosylation 0.00314 0.0552 
TCA Cycle 0.00331 0.0573 
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Most metabolites were significantly altered due to an overall down-
regulation of the protein expression profile associated to them. To 
understand and validate the high number of lipid-related candidates, we 
performed an untargeted lipidomic profiling of the ARPE-19 cells. We found 
an important number of significantly down-regulated features (Figure 13A) in 
hyperglycemic and hypoxic conditions (N25 and H25), which mainly 
corresponded to triacylglycerol (TG) species (Figure 13B). 
With the aim of validating other altered metabolites and enriched pathways, 
we performed untargeted metabolomics of the polar cell extracts. Among 
the most important metabolites identified, we highlight glutathione 
(transsulfuration pathway and one carbon metabolism) that was down-
regulated in N25 and H25 (Figure 14), and N-acetyl-neuraminic acid, N-
acetyl-glucosamine, alpha-D-Fucose and GDP-Fucose (Asparagine N-
linked glycosylation pathway, Figure 13). N-acetyl-neuraminic, N-acetyl-
glucosamine and GDP-Fucose were down-regulated only in hypoxic with 
hyperglycemic condition (H25). 
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Figure 13. Lipidomics results. (A) Volcano plots of the lipidomic 
analysis. (B) Distribution of lipid families annotated in LipidMaps from 
the down-regulated features (blue) in N25 and H25. TG: 
triacylglycerol; PS: phosphatidylserine; PI: phosphatidylinositol; PG: 
phosphatidylglycerol; PE: phosphatidyletanolamine; PC: 
phosphatidylcholine; PA: phosphatidic acid; DG: diacylglycerol. 
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Figure 14. Example of dysregulated metabolite (glutathione). 
Predicted from the collective enzyme abundance distribution (left) and 
further experimental validation by LC-MS (right). 
 
Figure 15. Significantly altered (*) metabolites in Asparagine N-
linked glycosylation pathway. N-acetyl-neuraminic acid, N-acetyl-
glucosamine and GDP-Fucose. 
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We further explored the clinical relevance of our results by analysing human 
vitreous humor samples from patients at different stages of DR, including 14 
controls (healthy retinas), 4 non-proliferative DR (NPDR), an early stage of 
DR, and 12 proliferative DR (PDR), the latest stage of DR. Our NMR and 
MS-based metabolomic analysis confirmed some of the altered pathways 
and metabolites reported in RPE cells by the metabolic network analysis. 
The most relevant metabolites are involved in trans-sulfuration, one carbon 
metabolism and methylation pathways, including N5-formyl-THF, S-
Adenosylhomocysteine (SAH), S-Adenosylmethionine (SAMe) and 
methionine, which appeared up-regulated in PDR (Figure 14). 
 
Figure 16. Trans-sulfuration and one carbon metabolism 
pathway. Showing exemples of experimentally detected altered 
metabolites found in vitreous humour. 
  
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
RESULTS 
130 
 
Remarkably, the ketone bodies 3-hydroy-butyrate and acetoacetate were 
up-regulated in PDR (Figure 17), suggestion an alteration in the metabolism 
of fatty acids at the late stage of DR. 
 
Figure 17. Ketone body metabolism. Showing experimentally 
detected 3-hydroxybutyrate and acetoacetate significantly up-
regulated in the vitreous humor of PDR patients. 
  
1.4 Discussion and conclusions 
Cellular response to genetic and environmental perturbations is often 
reflected and/or mediated through changes in the metabolism. Such 
metabolic changes are often exerted through transcriptional changes 
induced by complex regulatory mechanisms coordinating the activity of 
different metabolic pathways. It is difficult to map such global protein 
expression responses by using traditional statistical methods, because 
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many genes in the metabolic network have relatively small changes at their 
transcription/translation level. We therefore have developed an approach 
that integrates quantitative proteomics data with topological information from 
a human genome-scale metabolic model, showing that it is possible to 
reveal metabolites around which significant and coordinated protein 
expression changes occur in response to environmental perturbations, 
namely hypoxia and/or hyperglycemia. 
The significant metabolites, defined as reporter metabolites elsewhere13, 
mark spots in the metabolism where there is substantial regulation either to 
maintain homeostasis or adjust the concentration of the metabolite to 
another level required for proper functioning of the metabolic network under 
different environmental conditions. Conventional proteome analysis, in 
which differentially expressed proteins are identified by using a statistical 
test (e.g., t test analysis with Bonferroni correction), did not enable 
identification of the overall effect of hypoxia and/or hyperglycemia on the 
metabolism. Similar to protein-protein interaction networks, standard 
statistical analysis at the level of individual proteins, which assumes that 
metabolic enzymes are independent variables, show a strong bias toward 
highly up- and down-regulated proteins. In contrast, our metabolic network-
based approach exploits the highly interconnected nature of the metabolic 
network enabling identification of subtle but coordinated and collective 
protein expression changes at the system level. This idea originates from 
the observation that expression difference increases with metabolic network 
distance, demonstrating that genes closer to each other in metabolic 
network tend to have, on average, higher level of coexpression.14,15 
The integration of quantitative proteomics data from RPE cells under 
hyperglycemic and hypoxic conditions with metabolic networks resulted in 
the prediction of altered metabolites involved in one carbon metabolism16 
and associated pathways such as trans-sulfuration, methionine and folate 
cycle and methylation reactions. Remarkably, many of these predicted 
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metabolites were further analyzed by LC-MS, GC/MS and/or NMR and their 
altered abundance in human RPE cells and vitreous humor of DR patients 
was also confirmed.  Recently, Malaguarnera et al.17 found significantly 
higher plasma levels of homocysteine in NPDR patients compared to a 
control group, and in PDR patients compared to a control group and NPDR 
patients. The severity of diabetic retinopathy was associated with lower folic 
acid and red cell folate levels, and a significant difference was observed 
between PDR and NPDR groups. SAM/SAH ratio in plasma was inversely 
associated with retinal sclerotic vessel abnormalities and retinopathy in 
subjects with T2D18. 
In addition, our results highlight the importance of lipid (TG and fatty acids) 
and ketone bodies metabolism in RPE cells. Typically, ketone bodies are 
produced from acetyl-CoA, mainly in the mitochondrial matrix of liver cells 
when carbohydrates are so scarce that energy must be obtained from 
breaking down of fatty acids. However, extrahepatic ketogenesis has been 
also demonstrated in tumor cells, astrocytes of the central nervous system, 
the kidney, pancreatic β cells, retinal pigment epithelium (RPE), and even in 
skeletal muscle19. Recent observations underscore the importance of 
ketone bodies as vital metabolic and signaling mediators when 
carbohydrates are abundant20. 
In summary, this methodology shows the significance of studying metabolic 
problems from a network point of view and will raise awareness on future 
proteomics studies.  
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CHAPTER 2. Exploring the use of 
gas chromatography coupled to 
chemical ionization mass 
spectrometry (GC-CI-MS) for stable 
isotope labelling in metabolomics 
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2.1 Introduction 
Metabolomics is nowadays a well-established branch of the omics field. The 
ability to detect and quantify hundreds of different small organic compounds 
in complex biological samples makes metabolomics a powerful source of 
biological information. Due to the chemical diversity of naturally occurring 
metabolites, metabolomics is rich in analytical instrumentation and 
configurations, with GC/MS and LC-MS being the most common 
techniques.  
GC/MS has been the analytical platform of choice for measuring volatile 
compounds for decades1. However, with the introduction of chemical 
derivatization, and the inherent high-resolution chromatographic separations 
and low MS background noise, GC/MS-based metabolomics has evolved 
into a powerful analytical platform to produce compound abundance data in 
multiple types of targeted and untargeted metabolomic experiments2–7. GC 
systems are typically coupled to a single (GC-sQ) or triple quadrupole mass 
spectrometers (GC-QqQ) for targeted metabolomics, while untargeted 
analyses are generally performed using time-of-flight (GC-TOF) or Orbitrap 
(GC-Orbitrap) mass spectrometers. The most widely used ionization method 
in GC/MS is electron impact ionization (EI), a hard ionization strategy that 
generates highly reproducible and characteristic fragmentation spectra1. 
However, softer ionization techniques based on chemical ionization (CI) are 
alternative methods, where molecular ions of analyzed compounds are kept 
(mostly) intact8. 
The determination of relative or absolute metabolite concentrations by 
GC/MS can also be used to investigate the rate at which these compounds 
are being transformed into other intermediates by metabolic (i.e., enzymatic) 
activity, a field known as stable-isotope labellingand fluxomics9. Stable 
isotopes, such as 13C and 15N, are used to track the fate of a labelled 
nutrient, e.g. 13C-glucose or 13C/15N-glutamine, being a much safer 
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alternative to the formerly used radioactive isotopes.10–12 Metabolites 
enriched with stable isotopes maintain the original chemical structure and 
biochemical properties, but the different isotopic composition (i.e., 
isotopologues) cause a shift in their mass, which is detectable by MS. In this 
regard, GC-EI MS has become a platform of choice for stable isotope 
tracing studies and fluxomics approaches13–19. The coverage of GC-EI MS is 
comprehensive enough to cover most central carbon metabolism (i.e., 
glycolysis, TCA, amino acids, pentose phosphate pathway) thanks to the 
use of chemical derivatization. Although several tools for automated 
analysis of GC-EI MS data are available, including open source software20–
23, a few have been developed for stable-isotope labelling24–30. This is 
probably due to the difficulty in deconvoluting the intensity of overlapping 
isotopologues from EI mass spectra. Interestingly, the use of GC-CI MS for 
stable-isotope tracing is largely unexplored31–35. In here, we have studied 
the suitability of GC-CI-MS for stable-isotope tracing using multiple 
analytical configurations based on low-resolution and high-resolution mass 
spectrometry. We prove that isobutane is an ideal ionization gas by its 
ability to yield intact protonated molecular ions, and coupled to cutting-edge 
high-resolution GC/MS instruments, currently provide the best configuration 
for isotopologue quantification. In addition, we have developed an R-
package called isoSCAN capable of processing GC-CI MS data from stable-
isotope labelling studies.  
 
2.2 Results 
2.2.1 COMPARING ELECTRON IONIZATION (EI) WITH CHEMICAL IONIZATION 
(CI) FOR STABLE ISOTOPE LABELLING 
In order to optimize the detection of isotopologues using GC/MS, we first 
compared the performance of the most commonly used ionization sources 
in GC/MS: EI and CI.  
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In addition, we tested two different reagent gases for CI, namely methane 
and isobutane. Taking lactate as a reference metabolite in a complex 
biological sample, we found that CI with isobutane yielded most suitable 
spectra for stable isotope labelling experiments in comparison with EI 
(Figure 18). CI is a soft ionization method in which the abundance of a 
metabolite is concentrated in a few ions, facilitating the detection of isotopic 
enrichment, such as m+3 for lactate (m/z = 237.1) (Figure 18).  
 
Figure 18. Comparison of Lactate 2TMS spectra. Obtained from 
non-labelled (red) and 13C6-Glucose labelled (light blue) cell cultures. 
(Top) shows electron impact ionization fragment patterns. (Bottom) 
shows ions produced by chemical ionization, intact M+H ions are 
squared and zoomed in. 
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Figure 19. Chemical ionization and isobutane advantages. A,top. 
Chemical ionization spectra of Citrate 4TMS using Methane and 
Isobutane as reagent gases. B,bottom. Protonated (M+H+) ion 
abundance ratios (isobutane/methane) for glycolysis and TCA 
compounds. 
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In contrast, EI at 70 eV is a hard ionization method causing extensive 
fragmentation of compound structures in both non-labelled and labelled 
samples. This complicates the process of determining the amount of isotope 
labelling because the isotopic enrichment is scattered in multiple fragments. 
Notably, the use of isobutane as reagent gas produced mass spectra 
characterized by protonated molecular ions ([M+H]+) with practically 
undetectable in-source fragmentation, unlike methane gas that induced 
unwanted fragmentation of the protonated molecular ion (Figure 19A). This 
observation applied also to all intermediates of the glycolytic pathway and 
TCA cycle (Figure 19B), where the [M+H]+ ion was >5-fold more intense 
using isobutane than methane. Similarly, low-energy EI at 15 eV 29 also 
produced greater fragmentation of the molecular ion than CI-isobutane 
(Figure 20).  
Finally, we show that CI-isobutane can ionize efficiently most relevant 
metabolites in central carbon metabolism, including intermediates of 
glycolysis, TCA cycle, pentose phosphate pathway, amino acids, urea cycle 
and polyamines (Table 2.2, see end of chapter 2). In summary, CI with 
isobutane resulted in a broad coverage of metabolites and greater signal 
intensity of the [M+H]+ molecular ion for all standard metabolites tested.  
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Figure 20. Spectra obtained for Citrate 4TMS in EI 15eV and 70eV 
ionization. Showing lower intensity for intact ion (m/z 481.19) than in 
the case of CI and isobutane as a reagent gas. 
 
2.2.2 OPTIMIZING DATA ACQUISITION MODES IN GC-CI MS FOR STABLE 
ISOTOPE LABELLING  
The collection of mass analyzers used in hyphenated mass-spectrometry is 
very broad nowadays. We compared, therefore, the sensitivity, selectivity 
and isotope ratio fidelity of different mass analyzers and data acquisition 
modes for stable isotope labelling using GC CI-isobutane MS. In particular, 
we used a low-mass resolution configuration based on GC-CI triple 
quadrupole MS, and two high-mass resolution configurations based on GC-
CI qTOF MS and GC-CI qOrbitrap MS to analyze the same labelled and 
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non-labelled samples. In the case of the quadrupole configuration, we 
explored two acquisition modes to find the most sensitive and selective for 
our purposes: selected ion monitoring (SIM) and narrow scan (NS) 
acquisition (Figure 21).  
 
Figure 21. EICs obtained for corresponding Lactate 2TMS 
isotopologues in a triple quadrupole. Comparing NS (red) and SIM 
(blue) acquisition SNR and recorded units. Squared values are 
rounded Log10(SNR) values calculated per each EIC, which are 
several times larger for SIM compared to NS.  
 
SIM acquisition method was set to monitor single ions, that is, every 
isotopologue based on the number of carbons in each metabolite. In 
contrast, NS acquisition method was set to register a cluster of ions within a 
mass range that covers the full pattern of isotopologues of the derivatized 
metabolite (typically 8-10 Da), e.g. in the case of lactic acid (2TMS, m/z 
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235.1107) the quadrupole is set to scan a mass range from m/z 232.0 to 
240.0. Despite the greater signal intensity of NS, SIM yielded better signal-
to-noise ratio values, likely due to the greater ion selectivity of SIM (Figure 
21). The isotope ratio fidelity of NS and SIM, calculated as the relative 
deviation to the theoretical isotopic ratio, was similar for both acquisition 
methods which had a median value of ～10%, indeed fidelity relies on ion 
quantification, therefore low signal-to-noise ratio values foster fidelity values 
(Figure 22). 
 
Figure 22. Isotopologue abundances relative deviation in relation 
to theoretical natural abundances detected in a triple quadrupole. 
Blue shade indicates the range of relative theoretical abundance per 
ion. 
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Next, we compared the sensitivity, selectivity and isotope ratio fidelity of two 
high-mass resolution instruments: a GC-Orbitrap mass analyzer acquiring in 
full scan mode at ~60.000 resolution and a GC-qTOF mass analyzer 
acquiring in full scan mode at ~40.000 resolution. The deviation of isotope 
ratio of GC-CI qOrbitrap MS and GC-CI qTOF MS were <15% from the 
theoretical values, yet only the qOrbitrap was capable of clearly resolving 
natural isotopes from silicon (29Si and 30Si) from carbon, while in the case 
of the qTOF they were practically indistinguishable and thus were summed 
(Figure 23). As expected, the qOrbitrap showed a much higher mass 
accuracy (<1ppm) compared to the QTOF (<6ppm).  
 
Figure 23. Isotopologue abundances relative deviation in relation 
to theoretical natural abundances detected in QTOF and 
qOrbitrap instruments. Blue shade indicates the range of relative 
theoretical abundance per ion.  
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Remarkably, the qOrbitrap in full scan mode yielded greater sensitivity than 
SIM and NS acquisition, particularly when detecting labelled isotopologues 
of low abundant compounds detected in biological samples (Figure 24). 
Interestingly, when the quadrupole was set to filter the same mass range as 
in NS (i.e., 8-10 Da) with the aim of reducing the ion population in the 
orbitrap mass analyzer, we did not observe an increase in sensitivity in 
comparison with full scan acquisition (data not shown). As expected, both 
high-mass resolution instruments have the additional advantage that are 
more selective than SIM and NS at low-mass resolution, because the former 
can distinguish artifacts or compounds that could interfere with the 
isotopologues of interest. 
 
Figure 24. Comparison of relative abundances of isotopologue 
ions. Different compounds in triple quadrupole (blue) and qOrbitrap 
instruments (red). The spectra belong to a 13C labelled sample. 
In summary, our results demonstrate that the latest generation of high-mass 
resolution GC/MS instruments in full scan mode have similar or superior 
sensitivity than quadrupole-based mass analyzers, making GC-CI (with 
isobutane) Orbitrap MS the most suitable configuration for the detection of 
isotopologues due to its greater mass resolution and accuracy. 
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2.2.3 ISOSCAN: AN R PACKAGE TO PROCESS TARGETED GC-CI-MS 
DATA 
To extend high throughput capabilities of GC-CI-MS we have developed 
isoSCAN, an open-source R-based computational tool 
(https://github.com/jcapelladesto/isoSCAN).  isoSCAN encloses a 
complete workflow to perform high-throughput compound-driven 
isotopologues quantification in GC/MS data (either high or low resolution). 
isoSCAN capabilities have been assayed in several GC/MS isotope 
labelling studies36–39 isoSCAN computational workflow is summarized in 
Figure 6. First, it requires as input data (i) GC–MS files in open standard 
formats (mz(X)ML); (ii) a list of compounds to target with their associated 
molecular formulas, monoisotopic mass values, and estimated retention 
times (Table 2.2). Then, isotopologue peaks are picked within a specified 
retention time range through local maxima detection. This peak-picking step 
slightly differs from low to high mass resolution data. In the case of low 
resolution instruments, isotopologue mass is computed by adding 
corresponding enrichment isotope mass difference (i.e., 1.003355 for 13C) 
as many times as the maximum number of atoms present in the molecular 
formula (i.e.,  up to six times in the case of glucose (C6H12O6)). For high-
resolution data, the quantification supports both profile and centroided data, 
yet for computational reasons we recommend centroiding.   
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Figure 25. Data input and function hierarchy in isoSCAN.  
 
isoSCAN was developed to automatically quantify all the isotopologues of a 
given list of compounds. isoSCAN requires a list of compound formulas, 
their molecular ion m/z and their estimated retention times, in order to 
extract the abundances of isotopologue (Table 2.2). Additionally, the 
package includes functions for data transformation and plotting (Figure 25).  
The main feature of isoSCAN is that it searches, and quantifies, 
isotopologue peaks by looking for a local maximum using the retention time 
value as a guide. However, the peak finding algorithm is different depending 
on instrument resolution: 
- LR.autoQ. In the case of low resolution instruments, mainly nominal 
mass data, isotopologue masses are simply calculated by the 
addition of the mass difference corresponding to the labelling isotope 
of choice. 
- HR.autoQ. In the case of high resolution instruments, we observed 
that isotopologue mass calculation needs to be refined as data may 
include other isotopic distributions (Si, N or O) that are relatively less 
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intense but still must be considered for accurate quantification. 
Therefore, we use enviPat40 R package to calculate and merge the 
theoretical isotopic distribution for every possible labelled 
isotopologue, each is searched independently. Afterwards, 
isotopologue abundances are added by considering the number of 
labelled atoms to which each isotopologue corresponds (see below, 
Table 2, for an example in the case of isotopologues M+0 to M+3 of 
2TMS Lactate). 
 
Table 7. Isotopologues to consider in HRMS for Lactate 2TMS 
(C9H24O3Si2). Each color determines ions that should be summed 
for correct isotopologue estimation. 
m/z 
Num 
12C 
Num 
13C 
Num 
28Si 
Num 
29Si 
Num 
30Si 
236,1258 9 0 2 0 0 
237,1254 9 0 1 1 0 
237,1292 8 1 2 0 0 
238,1226 9 0 1 0 1 
238,1287 8 1 1 1 0 
238,1325 7 2 2 0 0 
239,1261 8 1 1 0 1 
239,1321 7 2 1 1 0 
239,1359 6 3 2 0 0 
240,1294 7 2 1 0 1 
240,1354 6 3 1 1 0 
241,1327 6 3 1 0 1 
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2.3 Discussion and conclusions 
MS is currently the preferred analytical technique used for measuring 
isotopic labelling of intracellular metabolites. In this regard, GC/MS is 
characterized by low cost and relatively simple maintenance, which makes it 
more affordable than LC-MS equipment by many individual laboratories. A 
desirable scenario of stable-isotope labelling is to measure isotopologue 
distributions in intact metabolites, however, the inherent fragmentation of EI 
(the most widespread used ionization mode in GC) cause scattered isotope 
patterns. To minimize fragmentation, different analytical strategies have 
been implemented, including chemical derivatization with N-methyl N-(tert-
butylsilyl)trifluoroacetamide (MTBSTFA)14, EI ionization at 15 eV 29 or the 
use of chemical ionization35. The latter has been traditionally implemented 
using methane as reagent gas29, however, isobutane produces superior 
analyte signal abundance to methane 41, resulting also in a predominant 
protonated adduct ion and less fragmentation. Here we have used this 
previous knowledge to demonstrate that CI-isobutane outperforms CI-
methane, EI at 70eV and EI at 15eV for isotopologue analysis by GC/MS. 
We have also shown that the metabolic coverage of CI-isobutane allows 
analysis of most relevant metabolites in central carbon metabolism with 
good ionization efficiency, including intermediates of glycolysis, TCA cycle, 
pentose phosphate pathway, amino acids, urea cycle and polyamines. In 
addition, we have benefited from this better suited ionization source to 
explore different acquisition modes from the most common mass analyzers 
in metabolomics: time-of-flight (TOF), orbitrap, and quadrupole. 
Quadrupoles act as low-resolution mass filters and can be placed in series 
(e.g., triple quadrupoles) to measure only a predefined targeted subset of 
ions, offering in principle the best sensitivity for measuring a single 
metabolite. Our results showed that monitoring every isotopologue by SIM 
or opening the quadrupole 8-10 Da to scan the whole cluster of 
isotopologues of a metabolite, yielded similar results with regard to 
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sensitivity; that is to say, despite the better signal-to-noise ratios of SIM or 
the higher absolute intensity counts of the narrow scan acquisition, the 
same isotopologues were detected for low abundant metabolites. The 
isotope ratio accuracy is slightly better for qOrbitrap due to its superior 
resolution and sensitivity. Remarkably, our results indicate that cutting-edge 
high-resolution GC/MS instruments have a comparable, or even better, 
performance than quadrupole systems, improving isotopologue 
quantification for low abundant compounds (e.g., dihydroxyacetone-
phosphate and aconitate) in complex biological samples. Barely detectable 
isotopologues in SIM and/or NS showed a considerably higher response in 
full scan acquisition mode with HRMS instruments such as GC Orbitrap MS. 
In addition, exact mass instruments bring the advantage of distinguishing 
m/z interferences that may hinder the quantification of isotopologues.  
Finally, we have developed a versatile open-source software that can 
automatically process low- and high-resolution isotopic labelling data 
produced with GC CI-isobutane coupled to quadrupole, TOF and orbitrap 
instruments.  
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Table 8. Compounds resolved using CI-isobutane detection and 
quantification. TMS (trimethyl-silyl); MA (methoxamine). *Method 2 
also includes part of TCA cycle and some aminoacids 
Compound 
Name 
RT 
(min) 
Compound 
Formula 
Detec-
ted 
deriva-
tive 
Derivative 
Formula 
Detecte
d m/z 
Method 1. Glycolysis, TCA and Aminoacids 
Proline 3,76 C5H9NO2 1TMS C8H18NO2Si 188,1101 
Pyruvate 3,9 C3H4O3 
TMS+ 
MA 
C7H16O3NSi 190,0891 
Lactate 4,01 C3H6O3 2TMS C9H24O3Si2 236,1263 
Valine 5,91 C5H11NO2 3TMS C11H30NO2Si3 262,1653 
Isoleucine 5,95 C6H13NO2 2TMS C12H29NO2Si2 276,1808 
Leucine 6,22 C6H13NO2 2TMS C12H29NO2Si2 276,1808 
Glycine 6,37 C2H5NO2 3TMS C11H30NO2Si3 292,1571 
Succinate 6,84 C4H4O4 2TMS C10H23O4Si2 263,1134 
Alanine 6,97 C3H7NO2 3TMS C12H32NO2Si3 306,1727 
Serine 7,03 C3H7NO3 3TMS C12H31NO3Si3 322,1683 
Fumarate 7,22 C4H2O4 2TMS C10H21O4Si2 261,0978 
Oxaloacetate 8,2 C4H2O5 
2TMS+
MA 
C11H24O5NSi2 306,1193 
Malate 8,95 C4H4O5 3TMS C13H31O5Si3 351,1479 
Aspartate 8,85 C4H7NO4 3TMS C13H31NO4Si3 350,1632 
Urea 9,28 CH4N2O 2TMS C7H21N2OSi2 205,1182 
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Ketoglutarate 9,88 C5H4O5 
2TMS+
MA 
C12H26O5NSi2 320,1349 
Phosphoenolpyruvat
e 
10,18 C3H3O6P 3TMS C12H30O6PSi3 385,1087 
Glutamate 10,35 C5H7O4N 3TMS C14H34O4NSi3 364,1795 
Glyceraldehyde 3-
phosphate 
11,44 C3H5O6P 
3TMS+
MA 
C13H35O6NPSi
3 
416,1509 
Aconitate 11,61 C6H3O6 3TMS C15H31O6Si3 391,1428 
Dihydroxyacetone 
phosphate 
11,66 C3H5O6P 
3TMS+
MA 
C13H35O6NPSi
3 
416,1509 
Glutamine 11,83 C5H9O3N2 3TMS C14H35O3N2Si3 363,1955 
Glycerate 2-
phosphate 
11,98 C3H5O7P 4TMS C15H40O7PSi4 475,1588 
Glycerate 3-
phosphate 
12,18 C3H5O7P 4TMS C15H40O7PSi4 475,1588 
Citrate 12,25 C6H5O7 4TMS C18H41O7Si4 481,1929 
Glucose 12,87 C6H12O6 
5TMS+
MA 
C22H56O6NSi5 570,2953 
Ribose 5-phosphate 13,76 C5H11O8P 
5TMS+
MA 
C21H54NO8PSi
5 
620,2505 
Arginine 14,43 C6H14N4O2 5 TMS C21H52N3O2Si5 520,0919 
Fructose 6-
phosphate 
15,05 C6H12O9P 
6TMS+
MA 
C25H65O9NPSi
6 
722,3012 
Glucose 6-phosphate 15,12 C6H12O9P 
6TMS+
MA 
C25H65O9NPSi
6 
722,3012 
Lysine 18,09 C6H14N2O2 4TMS C18H46N2O2Si4 435,2708 
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Compound 
Name 
RT 
(min) 
Compound 
Formula 
Detected 
derivative 
Derivative 
Formula 
Detected 
m/z 
Method 2*. Nitrogen metabolism 
Creatine 15,23 C4H9N3O2 3TMS C13H31N3OSi3 330,1841 
Agmatine 16,6 C5H14N4 3TMS C14H35N3Si3 330,2203 
Arginino-
succinate 
16,87 C10H18N4O6 5TMS C11H31N4O10Si5 607,3362 
Putrescine 16,97 C4H12N2 4TMS C16H45N2Si4 377,2643 
Ornithine 17,1 C5H12N2O2 3TMS C14H37N2O2Si3 349,2148 
Cadaverine 17,71 C5H14N2 4TMS C17H47N2Si4 391,2799 
Histamine 17,71 C5H9N3 3TMS C14H34N3Si3 328,2047 
Tyramine 18,36 C8H11NO 3TMS C17H36NOSi3 354,2091 
Citruline 19,31 C6H13N3O3 3TMS C15H38N3O3Si3 392,2206 
Spermidine 20,5 C7H19N3 5TMS C22H60N3Si5 506,3613 
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CHAPTER 3. geoRge: a 
computational tool to detect the 
presence of stable isotope 
labelling in LC/MS-based 
untargeted metabolomics 
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3.1 Introduction 
In metabolism, the level of intracellular metabolites remains stable and 
relatively constant by homeostatic mechanisms that regulate the flow of 
producing and consuming metabolic reactions in the cell1. Many diseases, 
however, are caused by disturbances in homeostasis that provoke changes 
in metabolic fluxes and thus metabolite levels2.  
Global metabolite profiling, also known as untargeted metabolomics, has 
become a powerful approach to provide information about metabolite 
levels3, which can be later used to interrogate mechanistic biochemistry in 
health and disease4. Despite that, conventional untargeted metabolomics 
experiments result in a static snapshot of metabolism that does not provide 
details about the evolution of metabolic fluxes aimed at maintaining 
homeostasis and metabolite concentrations. In this regard, modern stable-
isotope metabolic flux analysis is becoming an essential tool to unravel 
mechanisms of metabolic regulation and identify therapeutic targets in 
diseased cells5. This approach makes use of stable isotopically-labelled 
substrates (e.g., 13C-glucose, 13C-glutamine) to trace back the cellular fate 
of labelled atoms into the structures of transformed metabolites. With the 
advent of comprehensive metabolic profiling technologies such as LC/MS 
and GC/MS, it opens possibilities to broaden the coverage of stable-isotope 
tracing studies, allowing for an unbiased mapping of fluxes through multiple 
metabolic pathways6–9. 
However, global tracking of isotopic labels in untargeted LC/MS-based 
datasets has challenges that hamper the extraction and relative 
quantification of isotope peaks from labelled data. Lately, a collection of 
workflows and bioinformatic tools have been developed to automatically 
detect the isotopologues (i.e., labelled metabolite peaks) formed when 
employing stable-isotope labelling. Among these stand out X13CMS6, 
mzMatch-ISO7,10 and MetExtract8 which, each in their own way, share a 
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similar principle for annotating and quantifying monoisotopic and 
corresponding isotope-labelled peaks of metabolites. These tools are based 
on a brute force approach by iterating over all MS signal data in each mass 
spectrum using the theoretical mass difference between the light and heavy 
stable isotope, such as 12C and 13C. Based on our experience this type of 
iterative approach may lead to false positive results due to the massive 
number of peaks in the untargeted LC/MS-based datasets. 
Here we describe a novel approach for the annotation and relative 
quantification of isotope-labelled mass spectrometry data that benefits from 
a simple and robust trait of the labelled mass spectra when it is compared to 
the unlabelled equivalent. Spectral peaks originated from labelled 
metabolites show higher intensity or may even appear as new peaks in the 
mass spectra, in consequence being distinguishable features by statistical 
testing. We have exploited this trait to develop geoRge, a new 
computational tool written in the open language R that runs on features 
(unique m/z and RT) detected as using the widespreadly-used XCMS 
package11,12. The automated untargeted isotope annotation and relative 
quantification capabilities of geoRge are demonstrated by the analysis of 
LC/MS data from a human retinal pigment epithelium cell line (ARPE-19) 
grown on normal and high glucose concentrations that mimics diabetic 
retinopathy conditions in vitro. 
3.2 Results and discussion 
3.2.1 COMPUTATIONAL WORKFLOW 
Our computational approach works on the basis of an experimental design 
that includes replicates of unlabelled and labelled (e.g., D-[U-13C]-glucose) 
biologically equivalent samples. The computational tool uses four functions 
that are described below (Figure 26). 
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(i) Detection of putative incorporations: the function PuInc_seeker 
generates a list of mzRT features that we consider as isotopologues, 
namely metabolites that incorporate stable isotope atoms from the labelled 
source, mentioned in the following as PuInc. To do this, the function 
performs a Welch’s t-test to compare labelled and unlabelled biologically 
equivalent samples from the XCMS matrix of mzRT features, that is, the 
xcmsSet object. We set default p-value and fold-change thresholds at 0.05 
and 1.2 respectively--- yet this can be changed by the user--- to filter out 
non-significant features and retain those that are significantly up-regulated 
in the labelled samples by comparison with the unlabelled ones (Figure 
24A). PuInc_seeker entirely relies on statistical criteria for finding PuInc 
features. This allows us to assess the biological variability of the metabolic 
fate of labelled atoms at the first step of the workflow.  
Although the effort of generating more samples (i.e. an identical unlabelled 
sample for every labelled sample) might be seen as a minor limitation, this 
constitutes a major advantage of our method. Within the same experiment, 
our workflow allows studying both metabolites pool size (by comparing 
unlabelled samples) and stable isotope enrichment (by comparing 
unlabelled vs. labelled samples), which constitute key complementary 
metabolic results. 
Note: the reliance on XCMS to detect all isotopologues in the initial pre-
processing step is critical. Due to different experimental factors, there is not 
a perfect combination of parameters in XCMS---or any other existing peak-
picking tool--- that can detect all relevant features in an untargeted LC/MS-
based approach. This may impose some limitations to any computational 
approach for global tracking of isotopic labels since it is common for 
metabolites to be present as a combination of multiple isotopologues, many 
with low peak abundance.  
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Figure 26. Workflow for geoRge experiments. The experimental 
design includes N replicates of unlabelled and labelled biologically 
equivalent samples from different experimental conditions. geoRge 
implements four functions (PuInc_seeker, basepeak finder, 
label_compare and database_query are highlighted in black) on the 
output matrix of XCMS to find putative isotopologues and the 
monoisotopic (unlabelled) mass peaks of these isotopologues. Finally, 
it annotates metabolites using an internal database and the accurate 
mass of the monoisotopic mass peaks, and compares the relative 
labelling of each isotopologue between experimental conditions. 
UNIVERSITAT ROVIRA I VIRGILI 
FROM SPECTROMETRIC DATA TO METABOLIC NETWORKS: AN INTEGRATED VIEW OF CELL METABOLISM 
Jordi Capellades Tomàs 
 
RESULTS 
167 
 
 
Figure 27. Representation of geoRge’s principle. A) Metabolites 
that incorporate labelled atoms/moieties from the labelled source will 
appear anew or with greater intensity in the mass spectrum. The 
mzRT features (dots in the scatter plot) passing a fold-change and p-
value filter are associated with metabolites incorporating one or more 
stable isotope atoms. B) In order to find the unlabelled monoisotopic 
peak of the labelled metabolites in the LC/MS dataset, the mass of the 
up-regulated features is divided by the mass of the stable isotope 
atom (in carbon experiments is 13.003355). The resulting value 
corresponds to the maximum number of carbon atoms the given mass 
could have. This is used to obtain a vector of masses that are 
searched in the unlabelled samples using a certain retention time and 
mass error window. Herein, the example for ADP-mannose, showing 
three different labelling moieties, either 13C5, 
13C6 and 
13C11, which 
correspond to the different sugar substructures that conform the 
structure of this nucleotide sugar. 
 (ii) Finding the monoisotopic (unlabelled) mass peak: for each PuInc 
feature the function basepeak_finder looks for the monoisotopic (unlabelled) 
mzRT feature in the unlabelled samples, mentioned in the following as base 
peak. To do this, the function computes the maximum number of carbon 
atoms every PuInc can possibly contain by dividing its exact mass (mzmed 
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using XCMS nomenclature) by the atomic mass of the stable isotope (e.g., 
13.003355 for 13C). The resulting number is used to calculate a vector of 
masses that correspond to all candidate base peaks (Figure 27B). In order 
to find the presence of such base peaks in the unlabelled samples, the 
function determines a retention time window centered at the median 
retention time value (rtmed using XCMS nomenclature) of the PuInc feature 
and a mass error of 6.5 ppm. Any peak that does not fall within these two 
criteria is discarded. Next, both intensity and signal-to-noise (S/N) 
thresholds are applied to avoid annotation of unresolved peaks as base 
peaks. The mean intensity threshold is calculated in the unlabelled samples 
for each condition independently, which by default is set to 2000 counts 
(maxo value using XCMS nomenclature) --- yet the user can tune it as 
necessary. The minimum S/N applied is calculated from the 20th percentile 
of the total distribution of S/N in the XCMS dataset. Yet, if still more than 
one feature is found as base peak, the function only retains base peaks with 
an intensity of at least 70% of the highest candidate base peak. The aim of 
these thresholds is to minimize false positive base peaks due to the natural 
isotopic distribution of metabolites, instrumental noise or other unresolved 
peaks. Finally, every PuInc features linked to the same candidate base peak 
are grouped in one “incorporation ID”, mentioned in the following as incID. If 
more than one base peak is found for the same PuInc feature, the different 
base peaks are given distinct incIDs. 
This process is fairly time-efficient; the time required for completing the 
described workflow depends on the dimensions of the XCMS matrix, 
defined by the number of samples and mzRT features. Though the rate is 
about 500 mzRT features per minute on an average-performance computer 
(4GB RAM and a 2.3GHz dual core processor), meaning that a complete 
analysis for a 10.000 mzRT feature dataset of 20 samples is performed in 
less than 25 minutes. 
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(iii) Percentage of labelling: the function label_compare calculates the 
percentage of each PuInc (i.e., isotopologue) out of the sum of all PuInc in 
one IncID--- plus the base peak if present in the labelled samples. For each 
PuInc feature within a IncID group, its intensity is divided by the sum of all 
the other intensities and multiplied by 100. This is repeated for every 
replicate sample independently. Due to limitations of peak-picking 
algorithms, the output of this function is not intended to be an absolute 
quantification of the percentage of stable isotope labelling, but rather a 
relative quantification allowing a comparison of the level of isotope 
incorporation between experimental conditions (e.g., KO vs. wild-type). 
Manual extraction of raw signals from selected metabolites is preferred in 
order to quantify the percentage of labelling of isotopologues in an absolute 
manner.  
(iv) Database query: the function database_query matches automatically the 
candidate base peaks against the Human Metabolome Database (HMDB 
3.6)13,14 with the objective of knowing the putative identity of the labelled 
metabolites. The default settings of database_query include the most 
common ion adducts (M+H+, M-H2O+H
+, M+Na+, M+NH4
+, M-H-, M-H2O-H
-) 
for each ionisation mode, and a 12 ppm mass accuracy---yet these settings 
can be changed by the user. The user can easily extend the default library 
by incorporating additional metabolites to build a personal database.  
 
3.2.2 A COMPARATIVE ANALYSIS OF GEORGE AND X13CMS IN THE STUDY 
OF HUMAN RETINAL PIGMENT EPITHELIAL CELLS EXPOSED TO 
HYPERGLYCEMIC CONDITIONS  
Most investigations into the pathogenesis of diabetic retinopathy have been 
concentrated on the neural retina since this is where clinical lesions are 
manifested15–17. Recently, however, various abnormalities in the structural 
and secretory functions of retinal pigment epithelium (RPE) that are 
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essential for neuroretina survival, have been found in diabetic retinopathy18–
20. To illustrate the complete geoRge workflow described above, we 
investigated the changes in the labelling pattern occurring in human RPE 
cells exposed to hyperglycemic conditions, the major component of the 
diabetic milieu. In addition, we compared the results of geoRge with the 
outcome of X13CMS6, since both approaches rely entirely on XCMS 
parameters for mzRT feature selection, unlike MzMatch-ISO7 and 
MetExtract8. In this way, differences can be fully attributed to the alternative 
strategies for annotating and quantifying monoisotopic and isotope-labelled 
peaks (i.e., isotopologues) of geoRge and X13CMS. ARPE-19, a human 
RPE cell line, was cultured in triplicate in both unlabelled D-glucose and 
labelled D-[U-13C]-glucose under 2 biological conditions: normal glucose 
concentration (5.5 mM) and high glucose concentration (25 mM). The 
samples were analyzed using LC-ESI-qTOF MS in negative ionisation mode 
(see Methods section for further details). Raw LC/MS files have been 
deposited in MetaboLights with accession number MTBLS213. 
The XCMS dataset containing 14,607 mzRT features was used as input for 
geoRge and X13CMS. From 270 and 411 PuInc in normoglycemic and 
hyperglycemic conditions, respectively, 377 PuInc were associated with 
monoisotopic (unlabelled) base peaks in geoRge, totaling 271 IncID 
(Supplementary File 1 found in the Supporting Information of the paper21 ). 
In contrast, X13CMS detected 1,176 isotopologues (Supplementary File 2 
found in the Supporting Information of the paper21). The density distribution 
of m/z ions among the isotopologues found by geoRge and X13CMS is 
shown in Figure 25A, indicating that geoRge leads to greater detection of 
putative 13C incorporations in the low mass range than X13CMS. By contrast, 
X13CMS seems to find isotopologues evenly across the entire mass range, 
closely resembling the distribution of m/z ions of the xcmsSet object. The 
relationship between isotopologues shown in Figure 25B revealed that 21% 
of geoRge’s 13C incorporations are unique while the rest are also detected 
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by X13CMS. Yet the 879 putative incorporations by X13CMS (75% of the 
total) that are not detected by geoRge is a remarkable fact. A detailed 
examination of these isotopologues according to the number of 13C atoms 
incorporated, demonstrates that there is a predominance of 1-3 13C and >18 
13C in X13CMS compared with geoRge (Figure 28C).  
A manual inspection of the MS signals in the 1-3 13C range reveals natural 
abundance isotopic distributions, whereas incorporations of >18 13C 
(reaching up to 104 13C) relates mainly to false positives. This can be also 
observed through a scatter (volcano) plot (Figure 28D) that relates fold-
change to p-value between replicates of unlabelled and labelled 
hyperglycemic equivalent samples. The vast majority of mzRT features 
labelled as isotopologues by X13CMS are also present in the unlabelled 
samples with similar or even higher intensity (Figure 28D-E). Only 4% of the 
isotopologues correspond to significantly upregulated mzRT features in the 
labelled samples (Figure 28F). After database searching in the HMDB13,14 
and METLIN22, 45% and 57% of the candidate base peaks matched with 
known metabolites as [M-H]- ions, respectively. When this was done with 
X13CMS, only 27% and 38% matched with known metabolites. 
In summary, while geoRge detects apparently three times less 
incorporations of 13C than X13CMS, our results suggests that the latter 
approach generates many false positives that require extensive manual 
inspection.  
We further studied the changes in the labelling pattern occurring in ARPE-
19 cells exposed to hyperglycemic and normoglycemic conditions using 
exclusively geoRge. Our results indicate that high glucose concentrations 
activate additional metabolic reactions in RPE cells. Many metabolites 
belong to the central glycolytic route and nucleotide biosynthetic pathways. 
The identity of some of these metabolites was confirmed by MS/MS both in 
unlabelled and labelled samples. In order to elucidate the effect of 
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hyperglycemic conditions in ARPE-19 cells, the percentage of 13C labelling 
between normoglycemic and hyperglycemic conditions was compared using 
a Welch’s t-test for each PuInc feature (this process is performed by 
label_compare function). Out of 171 unique labelled metabolites, 88 
appeared differentially labelled.  
Among these, the percentage of labelled D-glucose (m+6 13C peak at 
185.0774) was, expectedly, enriched in hyperglycemic conditions relative to 
the normoglycemic samples. Interestingly, downstream intermediates of the 
glycolytic pathway such as 1,3-bisphosphoglycerate (m+3 13C peak at 
267.9597), either 2- or 3-phosphoglycerate (m+3 13C peak at 187.9961), 
and phosphoenolpyruvate (m+3 13C peak at 169.9861) appeared to 
incorporate similar percentages of the stable isotope in hyperglycemic and 
normoglycemic conditions. However, metabolites involved in and generated 
from the TCA cycle showed a clear reduction in 13C labelling in 
hyperglycemic conditions. These included malate (m+2 13C peak at 
135.0225) and citrate (m+2 13C peak at 193.02879), glutamate (m+2 13C 
peak at 148.0537) and carnosine (m+3 13C peak at 228.1092), a metabolite 
that is synthesized mainly through glutamate-histidine transformation 
(Figure 29).  
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Figure 28. Comparative analysis of geoRge and X13CMS.  
A) Density distribution of m/z ions among the isotopologues found by 
geoRge (red area) and X13CMS (green area). The black line shows 
the distribution of m/z ions of the xcmsSet object. B) Venn diagram 
shows the relationship between isotopologues detected using geoRge 
and X13CMS. C) Bar plot shows the distribution of isotopologues in 
geoRge and X13CMS according to the number of 13C atoms 
incorporated. D) Scatter (volcano) plot of the 879 unique 
isotopologues by X13CMS that relates the fold-change to p-value 
between the three replicates of unlabelled and labelled equivalent 
hyperglycemic samples. Green dots are significantly upregulated 
mzRT features in the labelled samples, which correspond to 4% of the 
total. Two black and two dark green dots are highlighted because their 
mass spectra is displayed in E) and F). 
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Figure 29. Summary of the effect of hyperglycemic conditions on 
ARPE-19 cells. TCA metabolites appear to have a diminished 
labelling proportion in comparison to normoglycemic conditions. 
Alternative pathways that promote labelling of pentose and hexose 
sugars in nucleotides or nucleotide sugar structures appear to have a 
much higher labelling proportion under high glucose concentrations. In 
contrast, the labelling percentage of polysaccharides (i.e., 
glycopolymers) is decreased relative to normoglycemic conditions. 
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Moreover, several metabolites containing pentose and hexose groups, as 
well as polymers consisting of glucose units were differentially labelled in 
hyperglycemic samples relative to the normoglycemic ones. Among these, 
myo-inositol bisphosphate (m+6 13C peak at 345.0118) and ADP-mannose 
(m+6 13C peak at 594.1006 corresponding to labelled mannose) was 
enriched in hyperglycemic conditions. Many nucleoside and nucleotide 
structures such as cytidine, uridine, CMP, UMP, AMP and GMP were highly 
enriched by m+5 13C in the hyperglycemic samples, which correlates with 
the incorporation of labelled ribose into their structures (Figure 30A). Finally, 
different polymers of glucose units tentatively assigned to sucrose, 
maltotriose and glycogen appeared to incorporate less 13C atoms in the 
hyperglycemic samples relative to the normoglycemic ones. Although we 
could not identify these polymers by MS/MS due to the lack of reference 
spectra in databases, the pattern of isotopologues reinforces the accurate 
mass matching assignments. Sucrose, a disaccharide combination of the 
monosaccharides glucose and fructose was enriched in the m+12 13C peak 
at 353.1512; maltotriose, a trisaccharide consisting of three glucose 
molecules was enriched in the m+6, m+12 and m+18 13C peaks at 
509.1867, 515.2067 and 521.2270 respectively; and glycogen, which 
according to HMDB contains 4 units of glucose, was enriched in the m+12 
and m+24 13C peaks at 677.2598 and 689.3020 respectively (Figure 30B). 
Note that the m/z 683.2759 was not annotated as m+18 13C peak because 
the intensity of this peak in unlabelled samples is higher than in labelled 
samples. The m/z 683.2759 may correspond to a glycogen form containing 
6 glucose units, unfortunately this mass is not linked with any compound in 
databases. 
3.3 Conclusions 
geoRge is an open easy-to-use tool that has been designed for rapid global 
tracking of stable isotope labelling in untargeted metabolomics. Here, we 
have demonstrated that the detection of new mass spectral peaks that 
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appear in samples that were fed an isotopically labelled precursor is a more 
robust strategy for tracking the fate of stable isotopes than iterative 
approaches over all MS signal data that are characteristic of existing tools. 
We anticipate that this approach will have the same outcome when using 
other atom variants (15N, 33S and 18O). Importantly, the raw LC/MS 
experimental data described herein is publicly available through 
MetaboLights23 to ensure data traceability and reproducibility, and enabling 
for comparison with other existing and future approaches. Similarly, geoRge 
is available as an R script at https://github.com/jcapelladesto/geoRge.  
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Figure 30. Labelling pattern of sugar-containing compounds.  
A) MS/MS spectra of unlabelled AMP and its m+5 13C isotopologue, 
showing that the fate of D-[U-13C]-glucose atoms is the ribose subunit 
of the nucleotide. Only the fragments including part or the complete 
pentose structure gain the equivalent mass difference of 13C. B) 
Hexose polymers showing the recursive incorporation pattern of 
m+6 13C units.  
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In the latest quarter of century, -omics technologies have evolved into a 
collection of well-suited tools to extract information about the phenome, 
genome and epigenome. Nonetheless, one needs to go downstream 
translation to get a complete systems view. This is especially relevant for 
multifactorial and polygenic diseases deriving in complex phenotypes. 
Proteomics and metabolomics are essential to characterize such complex 
phenotypes. However, despite the fact that the complementarity of 
metabolomics and proteomics data is clear on paper, there is not yet a 
consensus on how to integrate experimental fluxomics or metabolomics and 
proteomics datasets to interrogate metabolism systems-wise. In this regard, 
this thesis presents a novel methodology to do so using genome-scale 
metabolic network reconstructions. These networks provide a platform to 
interpret -omics data in a biochemically meaningful manner. They offer a 
powerful abstraction to simulate the set of metabolic fluxes through the 
network eventually defining the cellular phenotype.  
By employing the connectivity of Recon 2 (a genome-scale human 
metabolic reconstruction) I have developed a quantitative proteomics-
guided strategy to reveal potential metabolic alterations. The idea is that a 
coordinated imbalanced expression of enzymes, as detected per 
quantitative proteomics, would eventually have an effect on the 
concentration or flux of those metabolites involved in the reactions regulated 
by these enzymes. Based on the expression profile of enzymatic proteins 
and their connectivity in Recon 2, our method outputs a list of metabolites 
whose production and consumption are potentially dysregulated resulting in 
altered concentrations or imbalanced fluxes. This method does not take into 
consideration protein regulation dynamics such as post-translational 
regulation, feedback inhibition or high-order conformations. In addition, 
neither kinetic nor contraints-based modeling is used but, just the network 
topology to predict the impact of a perturbation in the absence of kinetic 
parameters thereof neglecting the dynamic component of the metabolic 
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network. It should be stated that our approach is not aimed to determine the 
absolute flux through this network as a formal fluxomics approach would do 
but rather to unbiasedly predict a set of metabolites with altered 
concentrations.  
Here, conversely to traditional proteomics analysis where proteins are 
statistically treated as if they operated independently, the levels of proteins 
associated to a metabolite transformation according to network topology are 
evaluated as a whole. This leads to a novel and much realistic framework to 
interrogate metabolism. In this thesis, I have demonstrated this novel 
approach to successfully predict a set of metabolites with proved 
imbalanced fluxes or abundances and that resulted overlooked by traditional 
statistical analysis.  Moreover, this has the potential to also be applied to 
transcriptomics data to the same end.  
 
We hypothesize, however, that due to the usually low correlation between 
transcriptome and proteome (27–40%), the predictive value of this approach 
will decrease with gene expression data. 
This novel method is not without limitations. On one hand, it requires a 
rather large coverage of the proteomics data so as to be able to map the 
maximum number of enzymatic reactions in the metabolic network. 
Metabolites whose reactions are left uncovered can not be tested. On the 
other hand, the statistical power of our binomial test dramatically decreases 
with metabolites that present a lower number of interconnections (usually 
end-products of synthesis or degradation pathways) and therefore our 
method is not sensitive enough to predict them.  
Next, in order to confirm predicted flux disturbances, I have developed two 
novel strategies aimed at high-throughput experimental determination of 
metabolic fluxes based on stable isotope labelling experiments. The first 
strategy consists of a GC/(CI)MS-based analytical method directed towards 
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high-throughput analysis and relative quantification of isotopologues of 
those intermediate metabolites in central carbon metabolism pathways: 
glycolysis, TCA cycle, pentose phosphate pathway and urea cycle. This 
experimental method is complemented by isoSCAN, an open-source 
package allowing automatic isotopologue quantification, isotopologue 
assignment, normalization and fractional enrichment, from either high or 
low-resolution GC/MS data. The second strategy is called to expand 
metabolic network coverage beyond this central carbon metabolism and 
therefore it uses an untargeted LC/(ESI)MS-based analytical approach to 
detect and quantify isotopologues. Again, to ease and automate data 
analysis I developed geoRge, an open-source package enclosing a 
statistically-oriented data analysis workflow to detect enriched isotopologue 
distributions in untargeted LC/MS data. These two strategies are called to 
simplify and automate isotope labelling experiments allowing high-
throughput measurement of fractional enrichment in a wide range of 
metabolite intermediates. This fractional enrichment can in turn be 
considered as a qualitative measure of flux. Thus, both strategies have 
significantly broadened the coverage of traditional stable isotope labelling 
experiments allowing for an unbiased mapping of fluxes through multiple 
metabolic pathways.  
Altogether, these three contributions provide novel tools to comprehensively 
interrogate metabolism. These tools have been successfully applied to the 
study of different phenotypes associated with cancer and diabetes where 
they have been shown to play a pivotal role in revealing, explaining and 
confirming major mechanistic insights.  
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Herein I list the main conclusions of this thesis, related to each objective: 
Objective 1: 
 Metabolic networks are an excellent framework to study the effects 
of protein expression on metabolism. 
 Annotating metabolic reactions with protein entities is an appropriate 
strategy to integrate metabolomics and proteomics. 
Objective 2: 
 Chemical ionization with isobutane as a reagent gas in gas 
chromatography coupled to high-resolution mass-spectrometers is 
an ideal setup for stable isotope labelling experiments. 
Objetive 3: 
 Statistical testing is a recommended option when performing the 
unbiased detection of enriched isotopologues in stable isotope 
labelling metabolomics experiments. 
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